Physical	O
interactions	O
between	O
Ets	B-protein
and	I-protein
NF-kappaB/NFAT	I-protein
proteins	I-protein
play	O
an	O
important	O
role	O
in	O
their	O
cooperative	O
activation	O
of	O
the	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
enhancer	I-DNA
in	O
T	B-cell_type
cells	I-cell_type
.	O

The	O
transcriptional	B-DNA
regulatory	I-DNA
elements	I-DNA
of	O
many	O
inducible	B-DNA
T-cell	I-DNA
genes	I-DNA
contain	O
adjacent	O
or	O
overlapping	B-DNA
binding	I-DNA
sites	I-DNA
for	O
the	O
Ets	B-protein
and	I-protein
NF-kappaB/NFAT	I-protein
families	I-protein
of	O
transcription	B-protein
factors	I-protein
.	O

Similar	O
arrays	O
of	O
functionally	O
important	O
NF-kappaB/NFAT	B-DNA
and	I-DNA
Ets	I-DNA
binding	I-DNA
sites	I-DNA
are	O
present	O
in	O
the	O
transcriptional	B-DNA
enhancers	I-DNA
of	O
human	O
immunodeficiency	O
viruses	O
types	O
1	O
and	O
2	O
(	O
HIV-1	O
and	O
HIV-2	O
)	O
,	O
suggesting	O
that	O
this	O
pattern	O
of	O
nuclear	B-DNA
protein	I-DNA
binding	I-DNA
sites	I-DNA
reflects	O
an	O
evolutionarily	O
conserved	O
mechanism	O
for	O
regulating	O
inducible	O
T-cell	O
gene	O
expression	O
that	O
has	O
been	O
co-opted	O
during	O
HIV	O
evolution	O
.	O

Despite	O
these	O
findings	O
,	O
the	O
molecular	O
mechanisms	O
by	O
which	O
Ets	B-protein
and	I-protein
NF-kappaB/NFAT	I-protein
proteins	I-protein
cooperatively	O
regulate	O
inducible	O
T-cell	O
gene	O
expression	O
remained	O
unknown	O
.	O

In	O
the	O
studies	O
described	O
in	O
this	O
report	O
,	O
we	O
demonstrated	O
a	O
physical	O
interaction	O
between	O
multiple	O
Ets	B-protein
and	I-protein
NF-kappaB/NFAT	I-protein
proteins	I-protein
both	O
in	O
vitro	O
and	O
in	O
activated	B-cell_type
normal	I-cell_type
human	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

This	O
interaction	O
is	O
mediated	O
by	O
the	O
Ets	B-DNA
domain	I-DNA
of	O
Ets	B-protein
proteins	I-protein
and	O
the	O
C-terminal	O
region	O
of	O
the	O
Rel	O
homology	O
domains	O
of	O
NF-kappaB/NFAT	B-protein
proteins	I-protein
.	O

In	O
addition	O
,	O
the	O
Ets	B-protein
-	O
NF-kappaB	B-protein
/	O
NFAT	B-protein
interaction	O
requires	O
the	O
presence	O
of	O
DNA	B-DNA
binding	I-DNA
sites	I-DNA
for	O
both	O
proteins	O
,	O
as	O
it	O
is	O
abolished	O
by	O
the	O
DNA	O
intercalating	O
agents	O
propidium	O
iodide	O
and	O
ethidium	O
bromide	O
and	O
enhanced	O
by	O
the	O
presence	O
of	O
synthetic	O
oligonucleotides	O
containing	O
binding	B-DNA
sites	I-DNA
for	O
Ets	B-protein
and	O
NF-kappaB	B-protein
proteins	I-protein
.	O

A	O
dominant-negative	O
mutant	O
of	O
NF-kappaB	B-protein
p50	I-protein
that	O
binds	O
DNA	O
but	O
fails	O
to	O
interact	O
with	O
Ets	B-protein
proteins	I-protein
inhibits	O
the	O
synergistic	O
activation	O
of	O
the	O
HIV-1	B-DNA
and	I-DNA
HIV-2	I-DNA
enhancers	I-DNA
by	O
NF-kappaB	B-protein
(	O
p50	B-protein
+	O
p65	B-protein
)	O
and	O
Ets-1	B-protein
,	O
suggesting	O
that	O
physical	O
interaction	O
between	O
Ets	B-protein
and	O
NF-kappaB	B-protein
proteins	I-protein
is	O
required	O
for	O
the	O
transcriptional	O
activity	O
of	O
the	O
HIV-1	B-DNA
and	I-DNA
HIV-2	I-DNA
enhancers	I-DNA
.	O

Taken	O
together	O
,	O
these	O
findings	O
suggest	O
that	O
evolutionarily	O
conserved	O
physical	O
interactions	O
between	O
Ets	B-protein
and	I-protein
NF-kappaB/NFAT	I-protein
proteins	I-protein
are	O
important	O
in	O
regulating	O
the	O
inducible	O
expression	O
of	O
T-cell	B-DNA
genes	I-DNA
and	O
viruses	O
.	O

These	O
interactions	O
represent	O
a	O
potential	O
target	O
for	O
the	O
development	O
of	O
novel	O
immunosuppressive	O
and	O
antiviral	O
therapies	O
.	O

JOURNAL	NULL
OF	NULL
ViroLOGYy	NULL
,	NULL
May	NULL
1997	NULL
,	NULL
p.	NULL
3563-3573	NULL
0022-538X	NULL
,	NULL
/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

71	NULL
,	NULL
No	NULL
.	NULL

5	NULL
Physical	NULL
Interactions	NULL
between	NULL
Ets	NULL
and	NULL
Proteins	NULL
Play	NULL
an	NULL
Important	NULL
Role	NULL
in	NULL
Their	NULL
Cooperative	NULL
Activation	NULL
of	NULL
the	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Enhancer	NULL
in	NULL
T	NULL
Cells	NULL
ALEXANDER	NULL
G.	NULL
BASSUK	NULL
,	NULL
ROSHANI	NULL
T.	NULL
ANANDAPPA	NULL
,	NULL
anp	NULL
JEFFREY	NULL
M.	NULL
LEIDEN®*	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Chicago	NULL
,	NULL
Chicago	NULL
,	NULL
Illinois	NULL
60637	NULL
Received	NULL
7	NULL
October	NULL
1996/Accepted	NULL
21	NULL
January	NULL
1997	NULL
The	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
of	NULL
many	NULL
inducible	NULL
T-cell	NULL
genes	NULL
contain	NULL
adjacent	NULL
or	NULL
overlapping	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Similar	NULL
arrays	NULL
of	NULL
functionally	NULL
important	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
and	NULL
Ets	NULL
binding	NULL
sites	NULL
are	NULL
present	NULL
in	NULL
the	NULL
transcriptional	NULL
enhancers	NULL
of	NULL
human	NULL
immunodeficiency	NULL
viruses	NULL
types	NULL
1	NULL
and	NULL
2	NULL
(	NULL
HIV-1	NULL
and	NULL
HIV-2	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
pattern	NULL
of	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
reflects	NULL
an	NULL
evolutionarily	NULL
conserved	NULL
mechanism	NULL
for	NULL
regulating	NULL
inducible	NULL
T-cell	NULL
gene	NULL
expression	NULL
that	NULL
has	NULL
been	NULL
co-opted	NULL
during	NULL
HIV	NULL
evolution	NULL
.	NULL

Despite	NULL
these	NULL
findings	NULL
,	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
Ets	NULL
and	NULL
NF-	NULL
<	NULL
B/	NULL
NFAT	NULL
proteins	NULL
cooperatively	NULL
regulate	NULL
inducible	NULL
T-cell	NULL
gene	NULL
expression	NULL
remained	NULL
unknown	NULL
.	NULL

In	NULL
the	NULL
studies	NULL
described	NULL
in	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrated	NULL
a	NULL
physical	NULL
interaction	NULL
between	NULL
multiple	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
proteins	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
activated	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
interaction	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
Ets	NULL
domain	NULL
of	NULL
Ets	NULL
proteins	NULL
and	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
the	NULL
Rel	NULL
homology	NULL
domains	NULL
of	NULL
NF-	NULL
<	NULL
B/NFAT	NULL
proteins	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
interaction	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
DNA	NULL
binding	NULL
sites	NULL
for	NULL
both	NULL
proteins	NULL
,	NULL
as	NULL
it	NULL
is	NULL
abolished	NULL
by	NULL
the	NULL
DNA	NULL
intercalating	NULL
agents	NULL
propidium	NULL
iodide	NULL
and	NULL
ethidium	NULL
bromide	NULL
and	NULL
enhanced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
synthetic	NULL
oligonucleotides	NULL
containing	NULL
binding	NULL
sites	NULL
for	NULL
Ets	NULL
and	NULL
NF-B	NULL
proteins	NULL
.	NULL

A	NULL
dominant-negative	NULL
mutant	NULL
of	NULL
NF-KB	NULL
p50	NULL
that	NULL
binds	NULL
DNA	NULL
but	NULL
fails	NULL
to	NULL
interact	NULL
with	NULL
Ets	NULL
proteins	NULL
inhibits	NULL
the	NULL
synergistic	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
and	NULL
HIV-2	NULL
enhancers	NULL
by	NULL
NF-KB	NULL
(	NULL
p50	NULL
+	NULL
p65	NULL
)	NULL
and	NULL
Ets-1	NULL
,	NULL
suggesting	NULL
that	NULL
physical	NULL
interaction	NULL
between	NULL
Ets	NULL
and	NULL
NF-KB	NULL
proteins	NULL
is	NULL
required	NULL
for	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
HIV-1	NULL
and	NULL
HIV-2	NULL
enhancers	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
evolutionarily	NULL
conserved	NULL
physical	NULL
interactions	NULL
between	NULL
Ets	NULL
and	NULL
NF-KB/NFAT	NULL
proteins	NULL
are	NULL
important	NULL
in	NULL
regulating	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
T-cell	NULL
genes	NULL
and	NULL
viruses	NULL
.	NULL

These	NULL
interactions	NULL
represent	NULL
a	NULL
potential	NULL
target	NULL
for	NULL
the	NULL
development	NULL
of	NULL
novel	NULL
immunosuppressive	NULL
and	NULL
antiviral	NULL
therapies	NULL
.	NULL

The	NULL
lineage-specific	NULL
and	NULL
inducible	NULL
expression	NULL
of	NULL
many	NULL
eukaryotic	NULL
genes	NULL
is	NULL
controlled	NULL
by	NULL
the	NULL
assembly	NULL
of	NULL
multipartite	NULL
complexes	NULL
of	NULL
transcription	NULL
factors	NULL
on	NULL
promoter	NULL
and	NULL
enhancer	NULL
elements	NULL
containing	NULL
complex	NULL
arrays	NULL
of	NULL
sequence-specific	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
assembly	NULL
of	NULL
these	NULL
transcription	NULL
factor	NULL
complexes	NULL
on	NULL
DNA	NULL
is	NULL
regulated	NULL
both	NULL
by	NULL
the	NULL
sequences	NULL
and	NULL
the	NULL
geometry	NULL
of	NULL
the	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
and	NULL
by	NULL
physical	NULL
interactions	NULL
between	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
themselves	NULL
.	NULL

In	NULL
many	NULL
cases	NULL
,	NULL
viral	NULL
pathogens	NULL
have	NULL
co-opted	NULL
these	NULL
cellular	NULL
regulatory	NULL
pathways	NULL
by	NULL
evolving	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
that	NULL
resemble	NULL
eukaryotic	NULL
enhancers	NULL
and	NULL
that	NULL
contain	NULL
binding	NULL
sites	NULL
for	NULL
multiple	NULL
cellular	NULL
transcription	NULL
factors	NULL
.	NULL

For	NULL
example	NULL
,	NULL
previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
types	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
and	NULL
2	NULL
(	NULL
HIV-2	NULL
)	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
regulated	NULL
by	NULL
viral	NULL
enhancers	NULL
that	NULL
contain	NULL
binding	NULL
sites	NULL
for	NULL
multiple	NULL
lymphoid-specific	NULL
and	NULL
ubiquitous	NULL
host	NULL
cell	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
NF-kB	NULL
(	NULL
14	NULL
,	NULL
22	NULL
,	NULL
77	NULL
,	NULL
89	NULL
)	NULL
,	NULL
Ets	NULL
(	NULL
35	NULL
,	NULL
38	NULL
,	NULL
52	NULL
,	NULL
86	NULL
,	NULL
89	NULL
)	NULL
,	NULL
NFAT	NULL
(	NULL
15	NULL
,	NULL
21	NULL
,	NULL
25	NULL
)	NULL
,	NULL
and	NULL
Sp1	NULL
(	NULL
61	NULL
,	NULL
89	NULL
)	NULL
proteins	NULL
.	NULL

Interestingly	NULL
,	NULL
adjacent	NULL
and/or	NULL
overlapping	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
binding	NULL
sites	NULL
have	NULL
also	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
regulatory	NULL
elements	NULL
of	NULL
several	NULL
inducible	NULL
lymphoid	NULL
genes	NULL
,	NULL
including	NULL
those	NULL
for	NULL
interleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
18	NULL
,	NULL
66	NULL
,	NULL
87	NULL
,	NULL
101	NULL
)	NULL
,	NULL
IL-2	NULL
(	NULL
15	NULL
,	NULL
41	NULL
,	NULL
42	NULL
,	NULL
79	NULL
,	NULL
80	NULL
,	NULL
87	NULL
)	NULL
,	NULL
and	NULL
IL-2	NULL
receptor	NULL
alpha	NULL
(	NULL
44	NULL
,	NULL
54	NULL
,	NULL
95	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
array	NULL
of	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
may	NULL
reflect	NULL
a	NULL
conserved	NULL
mechanism	NULL
for	NULL
regulating	NULL
inducible	NULL
lymphoid	NULL
gene	NULL
expression	NULL
.	NULL

*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Chicago	NULL
,	NULL
5841	NULL
S.	NULL
Maryland	NULL
Ave.	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
60637	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
773	NULL
)	NULL
702-1919	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
773	NULL
)	NULL
702-1385	NULL
.	NULL

3563	NULL
Members	NULL
of	NULL
the	NULL
NF-xB	NULL
family	NULL
,	NULL
which	NULL
include	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
p105	NULL
,	NULL
p100	NULL
,	NULL
p52	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
RelB	NULL
,	NULL
regulate	NULL
gene	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
extracellular	NULL
signals	NULL
and	NULL
are	NULL
known	NULL
to	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
the	NULL
development	NULL
and	NULL
function	NULL
of	NULL
multiple	NULL
mammalian	NULL
cell	NULL
lineages	NULL
(	NULL
57	NULL
,	NULL
99	NULL
)	NULL
.	NULL

Preformed	NULL
NF-kB	NULL
proteins	NULL
are	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
by	NULL
their	NULL
association	NULL
with	NULL
members	NULL
of	NULL
the	NULL
inhibitory	NULL
IxB	NULL
protein	NULL
family	NULL
(	NULL
4	NULL
,	NULL
94	NULL
)	NULL
.	NULL

In	NULL
response	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
extracellular	NULL
signals	NULL
,	NULL
IxB	NULL
proteins	NULL
are	NULL
phosphorylated	NULL
and	NULL
degraded	NULL
(	NULL
26	NULL
)	NULL
,	NULL
thereby	NULL
releasing	NULL
transcriptionally	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
which	NULL
trans-locate	NULL
to	NULL
the	NULL
nucleus	NULL
to	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
multiple	NULL
target	NULL
genes	NULL
(	NULL
1	NULL
,	NULL
5	NULL
,	NULL
6	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
includes	NULL
NFATI/NFATp	NULL
(	NULL
55	NULL
,	NULL
67	NULL
)	NULL
,	NULL
NFATe	NULL
(	NULL
55	NULL
,	NULL
73	NULL
)	NULL
,	NULL
NFAT3/NFATX	NULL
(	NULL
37	NULL
,	NULL
39	NULL
,	NULL
65	NULL
)	NULL
,	NULL
and	NULL
NFAT4	NULL
(	NULL
39	NULL
)	NULL
,	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
distantly	NULL
related	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
domains	NULL
of	NULL
NFAT	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
(	NULL
termed	NULL
the	NULL
Rel	NULL
homology	NULL
domains	NULL
[	NULL
Rel	NULL
HDs	NULL
]	NULL
)	NULL
display	NULL
low-level	NULL
but	NULL
significant	NULL
sequence	NULL
identity	NULL
(	NULL
41	NULL
,	NULL
42	NULL
,	NULL
73	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
some	NULL
NFAT	NULL
proteins	NULL
are	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
(	NULL
24	NULL
,	NULL
59	NULL
,	NULL
88	NULL
,	NULL
107	NULL
)	NULL
and	NULL
are	NULL
translo-cated	NULL
to	NULL
the	NULL
nucleus	NULL
following	NULL
T-cell	NULL
activation	NULL
(	NULL
58	NULL
,	NULL
83	NULL
)	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
suggest	NULL
that	NULL
NF-	NULL
«	NULL
kB/NFAT	NULL
family	NULL
members	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
both	NULL
HIV-1	NULL
and	NULL
HIV-2	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

First	NULL
,	NULL
functionally	NULL
important	NULL
binding	NULL
sites	NULL
for	NULL
NF-	NULL
«	NULL
kB	NULL
and	NULL
NFAT	NULL
proteins	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
two	NULL
enhancers	NULL
(	NULL
15	NULL
,	NULL
21	NULL
,	NULL
35	NULL
,	NULL
71	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
overexpression	NULL
of	NULL
NF-kB	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
transac-tivate	NULL
reporter	NULL
constructs	NULL
driven	NULL
by	NULL
the	NULL
HIV-1	NULL
and	NULL
HIV-2	NULL
enhancers	NULL
(	NULL
29	NULL
,	NULL
62	NULL
,	NULL
71	NULL
,	NULL
84	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
NF-KB	NULL
activates	NULL
transcription	NULL
and	NULL
induces	NULL
chromatin	NULL
rearrangement	NULL
of	NULL
the	NULL
HIV-1	NULL
en-	NULL
3564	NULL
BASSUK	NULL
ET	NULL
AL	NULL
.	NULL

hancer	NULL
in	NULL
vitro	NULL
in	NULL
combination	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
Sp1	NULL
,	NULL
LEF-1	NULL
,	NULL
and	NULL
TFE-3	NULL
(	NULL
77	NULL
,	NULL
89	NULL
)	NULL
.	NULL

Like	NULL
the	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
proteins	NULL
,	NULL
Ets	NULL
transcription	NULL
factors	NULL
belong	NULL
to	NULL
a	NULL
large	NULL
multigene	NULL
family	NULL
with	NULL
at	NULL
least	NULL
17	NULL
mammalian	NULL
members	NULL
(	NULL
2	NULL
,	NULL
20	NULL
,	NULL
60	NULL
,	NULL
97	NULL
,	NULL
105	NULL
)	NULL
.	NULL

All	NULL
Ets	NULL
proteins	NULL
share	NULL
an	NULL
evolutionarily	NULL
conserved	NULL
82-amino-acid	NULL
(	NULL
aa	NULL
)	NULL
winged-helix-loop-helix	NULL
DNA	NULL
binding	NULL
domain	NULL
that	NULL
is	NULL
structurally	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
proteins	NULL
(	NULL
7	NULL
,	NULL
47	NULL
,	NULL
53	NULL
,	NULL
74	NULL
,	NULL
76	NULL
,	NULL
98	NULL
)	NULL
.	NULL

Like	NULL
NF-	NULL
«	NULL
B/	NULL
NFAT	NULL
family	NULL
members	NULL
,	NULL
Ets	NULL
proteins	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
regulating	NULL
the	NULL
expression	NULL
of	NULL
multiple	NULL
eukaryotic	NULL
genes	NULL
and	NULL
in	NULL
the	NULL
development	NULL
and	NULL
function	NULL
of	NULL
multiple	NULL
hematopoietic	NULL
cell	NULL
lineages	NULL
(	NULL
8	NULL
,	NULL
10	NULL
,	NULL
11	NULL
,	NULL
68	NULL
,	NULL
70	NULL
,	NULL
75	NULL
,	NULL
85	NULL
,	NULL
93	NULL
,	NULL
108	NULL
)	NULL
.	NULL

A	NULL
large	NULL
body	NULL
of	NULL
evidence	NULL
suggests	NULL
that	NULL
Ets	NULL
proteins	NULL
also	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
HIV-1	NULL
and	NULL
HIV-2	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
functionally	NULL
important	NULL
Ets	NULL
binding	NULL
site	NULL
has	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
(	NULL
38	NULL
,	NULL
40	NULL
,	NULL
86	NULL
)	NULL
.	NULL

Ets-1	NULL
,	NULL
Ets-2	NULL
,	NULL
and	NULL
Fli-1	NULL
have	NULL
all	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
this	NULL
site	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
these	NULL
proteins	NULL
can	NULL
transcriptionally	NULL
trans-activate	NULL
reporter	NULL
constructs	NULL
containing	NULL
multiple	NULL
copies	NULL
of	NULL
this	NULL
site	NULL
5	NULL
'	NULL
of	NULL
a	NULL
heterologous	NULL
promoter	NULL
(	NULL
38	NULL
,	NULL
40	NULL
,	NULL
86	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
synergistically	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
in	NULL
vitro	NULL
when	NULL
it	NULL
is	NULL
combined	NULL
with	NULL
purified	NULL
Sp1	NULL
and	NULL
Ets	NULL
proteins	NULL
(	NULL
77	NULL
,	NULL
89	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
two	NULL
functionally	NULL
important	NULL
Ets	NULL
binding	NULL
sites	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
HIV-2	NULL
enhancer	NULL
,	NULL
and	NULL
both	NULL
Elf-1	NULL
and	NULL
Ets-1	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
these	NULL
sites	NULL
in	NULL
vitro	NULL
(	NULL
16	NULL
,	NULL
32	NULL
,	NULL
52	NULL
,	NULL
63	NULL
,	NULL
64	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
evidence	NULL
that	NULL
NF-	NULL
«	NULL
kB/NFAT	NULL
and	NULL
Ets	NULL
proteins	NULL
are	NULL
each	NULL
important	NULL
regulators	NULL
of	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
HIV-1	NULL
and	NULL
HIV-2	NULL
,	NULL
it	NULL
remained	NULL
unclear	NULL
if	NULL
members	NULL
of	NULL
these	NULL
two	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
function	NULL
independently	NULL
or	NULL
cooperatively	NULL
to	NULL
regulate	NULL
inducible	NULL
HIV	NULL
gene	NULL
expression	NULL
.	NULL

Moreover	NULL
,	NULL
it	NULL
was	NULL
unclear	NULL
if	NULL
direct	NULL
physical	NULL
interactions	NULL
between	NULL
NF-	NULL
«	NULL
kB/NFAT	NULL
and	NULL
Ets	NULL
proteins	NULL
play	NULL
a	NULL
role	NULL
in	NULL
regulating	NULL
their	NULL
transcriptional	NULL
activity	NULL
on	NULL
the	NULL
HIV	NULL
enhancers	NULL
.	NULL

In	NULL
the	NULL
studies	NULL
described	NULL
in	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
(	NULL
i	NULL
)	NULL
demonstrated	NULL
physical	NULL
interactions	NULL
between	NULL
multiple	NULL
Ets	NULL
proteins	NULL
and	NULL
NF-kB/NFAT	NULL
family	NULL
members	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
mapped	NULL
the	NULL
interaction	NULL
domains	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domains	NULL
of	NULL
each	NULL
of	NULL
the	NULL
proteins	NULL
(	NULL
the	NULL
Ets	NULL
domains	NULL
of	NULL
the	NULL
Ets	NULL
proteins	NULL
and	NULL
the	NULL
Rel	NULL
HDs	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kB/NFAT	NULL
proteins	NULL
)	NULL
,	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
shown	NULL
that	NULL
physical	NULL
interactions	NULL
between	NULL
specific	NULL
Ets	NULL
and	NULL
NF-	NULL
<	NULL
B/NFAT	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
proteins	NULL
to	NULL
synergistically	NULL
regulate	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
HIV-1	NULL
and	NULL
HIV-2	NULL
enhancers	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
evolutionarily	NULL
conserved	NULL
physical	NULL
interactions	NULL
between	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
kB/NFAT	NULL
family	NULL
members	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
multiple	NULL
viral	NULL
and	NULL
cellular	NULL
genes	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
.	NULL

A	NULL
full-length	NULL
cDNA	NULL
for	NULL
NFATc	NULL
was	NULL
obtained	NULL
by	NULL
reverse	NULL
transcrip-tion-PCR	NULL
done	NULL
with	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
Pharmacia	NULL
Biotechnology	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
used	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
,	NULL
with	NULL
mRNA	NULL
isolated	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
following	NULL
4	NULL
h	NULL
of	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
and	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
73	NULL
)	NULL
,	NULL
and	NULL
the	NULL
following	NULL
synthetic	NULL
nucleotides	NULL
:	NULL
5	NULL
primer	NULL
GGG	NULL
CTC	NULL
GAG	NULL
GAT	NULL
CCC	NULL
ATG	NULL
CCA	NULL
AGC	NULL
ACC	NULL
AGC	NULL
TTT	NULL
C	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
GGG	NULL
TCT	NULL
AGA	NULL
GGA	NULL
TCC	NULL
TTA	NULL
GAA	NULL
AAA	NULL
GCA	NULL
CCC	NULL
CAC	NULL
.	NULL

Truncations	NULL
of	NULL
NFATe	NULL
were	NULL
made	NULL
using	NULL
PCR	NULL
with	NULL
the	NULL
following	NULL
primers	NULL
:	NULL
for	NULL
NFATc	NULL
;	NULL
4	NULL
;	NULL
,	NULL
,	NULL
5	NULL
'	NULL
primer	NULL
CCG	NULL
CTC	NULL
GAG	NULL
CGG	NULL
ATC	NULL
CCC	NULL
ATG	NULL
CCA	NULL
AGC	NULL
ACC	NULL
AGC	NULL
TTT	NULL
CCA	NULL
GTC	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
TGC	NULL
TCT	NULL
AGA	NULL
GGA	NULL
TCC	NULL
CTA	NULL
CCA	NULL
GTC	NULL
CAG	NULL
GGC	NULL
GGG	NULL
CAG	NULL
GGT	NULL
CGG	NULL
;	NULL
for	NULL
1g	NULL
5	NULL
``	NULL
primer	NULL
CCG	NULL
CTC	NULL
GAG	NULL
CGG	NULL
ATC	NULL
CCC	NULL
CAG	NULL
CTG	NULL
CCG	NULL
TCC	NULL
CAC	NULL
TCA	NULL
GGC	NULL
CCG	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
TGC	NULL
TCT	NULL
AGA	NULL
GGA	NULL
TCC	NULL
CTA	NULL
CTC	NULL
ATG	NULL
TTC	NULL
ACG	NULL
GCT	NULL
TAC	NULL
GGT	NULL
TAG	NULL
.	NULL

Full-length	NULL
and	NULL
truncated	NULL
NFATp	NULL
,	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
Elf-1	NULL
and	NULL
Ets-1	NULL
cDNAs	NULL
were	NULL
prepared	NULL
by	NULL
PCR	NULL
,	NULL
using	NULL
as	NULL
templates	NULL
the	NULL
previously	NULL
described	NULL
plasmids	NULL
pBS	NULL
NFATp	NULL
(	NULL
67	NULL
)	NULL
,	NULL
pRSV	NULL
p50	NULL
(	NULL
49	NULL
)	NULL
,	NULL
pRSV	NULL
p65	NULL
(	NULL
81	NULL
,	NULL
82	NULL
)	NULL
,	NULL
pRSV	NULL
c-Rel	NULL
(	NULL
13	NULL
,	NULL
22	NULL
)	NULL
,	NULL
peDNA3	NULL
Ets-1	NULL
(	NULL
3	NULL
)	NULL
,	NULL
peDNA1-neoElf-1	NULL
(	NULL
52	NULL
)	NULL
and	NULL
the	NULL
following	NULL
oligonucleotide	NULL
primers	NULL
:	NULL
for	NULL
J.	NULL
ViRoL	NULL
.	NULL

NFATp	NULL
,	NULL
5	NULL
primer	NULL
CTA	NULL
GTC	NULL
TAG	NULL
AGG	NULL
CGG	NULL
CTC	NULL
CTC	NULL
TGC	NULL
CAG	NULL
CTT	NULL
CAT	NULL
TTC	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
CTA	NULL
GTC	NULL
TAG	NULL
ATC	NULL
AGA	NULL
TCC	NULL
AGC	NULL
CTG	NULL
GGC	NULL
TAG	NULL
CAA	NULL
C	NULL
;	NULL
for	NULL
NFATp	NULL
;	NULL
_5	NULL
»	NULL
,	NULL
,	NULL
5	NULL
'	NULL
primer	NULL
CTA	NULL
GTC	NULL
TAG	NULL
AGG	NULL
CGG	NULL
CTC	NULL
CTC	NULL
TGC	NULL
CAG	NULL
CTT	NULL
CAT	NULL
TTC	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
CTA	NULL
GTC	NULL
TAG	NULL
ACT	NULL
AAG	NULL
ATG	NULL
GTT	NULL
CAT	NULL
ACT	NULL
CAT	NULL
CGC	NULL
TGG	NULL
G	NULL
;	NULL
for	NULL
NFATps	NULL
»	NULL
;	NULL
s5p	NULL
,	NULL
5°	NULL
primer	NULL
CTA	NULL
GTC	NULL
TAG	NULL
ATT	NULL
GAT	NULL
CTG	NULL
CAG	NULL
CCC	NULL
CGC	NULL
CCA	NULL
TGG	NULL
AG	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
CTA	NULL
GTC	NULL
TAG	NULL
ATC	NULL
AGA	NULL
TCC	NULL
AGC	NULL
CTG	NULL
GGC	NULL
TAG	NULL
CAA	NULL
C	NULL
;	NULL
for	NULL
p50	NULL
;	NULL
357	NULL
,	NULL
5	NULL
'	NULL
primer	NULL
GGG	NULL
CCG	NULL
CTC	NULL
GAG	NULL
CTG	NULL
CCA	NULL
ACA	NULL
GCA	NULL
GAT	NULL
GGC	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
ATC	NULL
GGG	NULL
CCC	NULL
CTA	NULL
GAG	NULL
CTT	NULL
CTG	NULL
ACG	NULL
TTT	NULL
CCT	NULL
C	NULL
;	NULL
for	NULL
p65	NULL
,	NULL
5°	NULL
primer	NULL
G	NULL
CCG	NULL
CTC	NULL
GAG	NULL
ATG	NULL
GAC	NULL
GAA	NULL
CTG	NULL
TTC	NULL
CCC	NULL
CTC	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
G	NULL
TGC	NULL
TCT	NULL
AGA	NULL
TTA	NULL
GGA	NULL
GCT	NULL
GAT	NULL
CTG	NULL
ACT	NULL
CAG	NULL
CAG	NULL
;	NULL
for	NULL
p65	NULL
;	NULL
;	NULL
3	NULL
,	NULL
,	NULL
,	NULL
5	NULL
'	NULL
primer	NULL
GGG	NULL
CCG	NULL
CTC	NULL
GAG	NULL
GAG	NULL
CCA	NULL
GCC	NULL
CAG	NULL
GCC	NULL
TCT	NULL
G	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
GTG	NULL
CTC	NULL
TAG	NULL
ACT	NULL
ATG	NULL
TCC	NULL
TTT	NULL
TAC	NULL
GTT	NULL
TCT	NULL
CCT	NULL
CAA	NULL
TC	NULL
;	NULL
for	NULL
c-Rel	NULL
;	NULL
p95	NULL
,	NULL
5	NULL
'	NULL
primer	NULL
GGG	NULL
CCG	NULL
CTC	NULL
GAG	NULL
ATG	NULL
GCC	NULL
TC	NULL
GGT	NULL
GCG	NULL
TAT	NULL
AAC	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
C	NULL
TAG	NULL
TCT	NULL
AGA	NULL
CTA	NULL
TGT	NULL
CTT	NULL
TTG	NULL
TTT	NULL
CTT	NULL
TGC	NULL
;	NULL
for	NULL
Elf-1	NULL
,	NULL
5	NULL
``	NULL
primer	NULL
GGG	NULL
CTC	NULL
GAG	NULL
GAT	NULL
CCC	NULL
ATG	NULL
GCT	NULL
GCT	NULL
GTT	NULL
GTC	NULL
CAA	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
CCC	NULL
GGG	NULL
TCT	NULL
AGA	NULL
TAA	NULL
CTA	NULL
AAA	NULL
AGA	NULL
GTT	NULL
GGG	NULL
TTC	NULL
CAG	NULL
C	NULL
;	NULL
for	NULL
Elf-19p	NULL
§19	NULL
,	NULL
5°	NULL
primer	NULL
GGG	NULL
CTC	NULL
GAG	NULL
GAT	NULL
CCC	NULL
AAA	NULL
CCA	NULL
GGG	NULL
AAT	NULL
TCT	NULL
AAA	NULL
GC	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
CCC	NULL
GGG	NULL
TCT	NULL
AGA	NULL
TAA	NULL
CTA	NULL
AAA	NULL
AGA	NULL
GTT	NULL
GGG	NULL
TTC	NULL
CAG	NULL
C	NULL
;	NULL
for	NULL
395	NULL
,	NULL
5°	NULL
primer	NULL
GGG	NULL
CTC	NULL
GAG	NULL
GAT	NULL
CCC	NULL
GTG	NULL
AAG	NULL
AAG	NULL
AAA	NULL
AAC	NULL
AAA	NULL
GAT	NULL
GG	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
GGG	NULL
TCT	NULL
AGA	NULL
GGA	NULL
TCC	NULL
CTA	NULL
ATC	NULL
TTT	NULL
TGG	NULL
CAT	NULL
TTC	NULL
TTT	NULL
AAA	NULL
C	NULL
;	NULL
for	NULL
Ets-133	NULL
;	NULL
412	NULL
,	NULL
5	NULL
'	NULL
primer	NULL
GGG	NULL
CTC	NULL
GAG	NULL
GAT	NULL
CCC	NULL
GGC	NULL
AGT	NULL
GGA	NULL
CCA	NULL
ATC	NULL
CAG	NULL
CTA	NULL
TGG	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
GGG	NULL
TCT	NULL
AGA	NULL
GGA	NULL
TCC	NULL
CTA	NULL
CAG	NULL
GTC	NULL
ACA	NULL
CAC	NULL
AAA	NULL
GCG	NULL
GTA	NULL
C.	NULL
Full-length	NULL
NFATe	NULL
,	NULL
NFATc	NULL
,	NULL
NFATcHqs	NULL
716	NULL
P5Qse-347	NULL
,	NULL
full-length	NULL
p65	NULL
,	NULL
P6511-304	NULL
)	NULL
C-Rel	NULL
;	NULL
795	NULL
,	NULL
full-length	NULL
Elf-1	NULL
,	NULL
417	NULL
Elf-1299	NULL
519	NULL
£W-1196-205	NULL
,	NULL
El-1209519	NULL
,	NULL
and	NULL
Ets-1331	NULL
41	NULL
,	NULL
cDNAs	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
XhoI	NULL
and	NULL
Xbel	NULL
sites	NULL
of	NULL
the	NULL
peDNA3HA	NULL
plasmid	NULL
,	NULL
which	NULL
contains	NULL
an	NULL
HA	NULL
epitope	NULL
tag	NULL
(	NULL
encoding	NULL
amino	NULL
acids	NULL
MG	NULL
YP	NULL
Y	NULL
DVP	NULL
D	NULL
Y	NULL
A	NULL
S	NULL
M	NULL
)	NULL
in	NULL
the	NULL
EcoRV	NULL
and	NULL
Xhol	NULL
sites	NULL
of	NULL
the	NULL
pecDNA3-Neo	NULL
plasmid	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
full-length	NULL
and	NULL
truncated	NULL
cDNAs	NULL
of	NULL
NFATp	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
Xbal	NULL
site	NULL
of	NULL
pcDNA3HA	NULL
.	NULL

The	NULL
full-length	NULL
cDNA	NULL
for	NULL
p50	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
XhoI	NULL
and	NULL
Apel	NULL
sites	NULL
of	NULL
pcDNA3	NULL
;	NULL
p50	NULL
,	NULL
,	NULL
,	NULL
,	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
Xhol-4peal	NULL
sites	NULL
of	NULL
pcDNA3HA	NULL
.	NULL

peDNA3	NULL
Ets-1	NULL
(	NULL
3	NULL
)	NULL
and	NULL
peDNA3	NULL
PU.1	NULL
(	NULL
33	NULL
)	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
.	NULL

The	NULL
chimeras	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
were	NULL
constructed	NULL
by	NULL
the	NULL
overlap	NULL
extension	NULL
method	NULL
of	NULL
PCR	NULL
,	NULL
using	NULL
the	NULL
following	NULL
sets	NULL
of	NULL
primers	NULL
:	NULL
for	NULL
p50/p65	NULL
chimera	NULL
1	NULL
,	NULL
5	NULL
'	NULL
primer	NULL
1	NULL
GGG	NULL
CCG	NULL
CTC	NULL
GAG	NULL
CTG	NULL
CCA	NULL
ACA	NULL
GCA	NULL
GAT	NULL
GGC	NULL
,	NULL
3	NULL
'	NULL
primer	NULL
1	NULL
GCC	NULL
TGA	NULL
TGG	NULL
GTC	NULL
CCG	NULL
CAC	NULL
TGT	NULL
AGC	NULL
TGT	NULL
AAA	NULL
CAT	NULL
GAG	NULL
CCG	NULL
CAC	NULL
,	NULL
5	NULL
'	NULL
primer	NULL
2	NULL
GTG	NULL
CGG	NULL
CTC	NULL
ATG	NULL
TTT	NULL
ACA	NULL
GCT	NULL
ACA	NULL
GTG	NULL
CGG	NULL
GAC	NULL
CCA	NULL
TCA	NULL
GGC	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
2	NULL
GTG	NULL
CTC	NULL
TAG	NULL
ACT	NULL
ATG	NULL
TCC	NULL
TTT	NULL
TAC	NULL
GTT	NULL
TCT	NULL
CCT	NULL
CAA	NULL
TC	NULL
;	NULL
for	NULL
p65/p50	NULL
chimera	NULL
3	NULL
,	NULL
5	NULL
'	NULL
primer	NULL
1	NULL
GGG	NULL
CCG	NULL
CTC	NULL
GAG	NULL
GAG	NULL
CCA	NULL
GCC	NULL
CAG	NULL
GCC	NULL
TCT	NULL
G	NULL
,	NULL
3	NULL
'	NULL
primer	NULL
1	NULL
CAG	NULL
TGC	NULL
TAT	NULL
CCG	NULL
GAA	NULL
GAA	NULL
ACA	NULL
CCT	NULL
GGA	NULL
AGC	NULL
AGA	NULL
GCC	NULL
GCA	NULL
C	NULL
,	NULL
5	NULL
``	NULL
primer	NULL
2	NULL
GTG	NULL
CGG	NULL
CTC	NULL
TGC	NULL
TTC	NULL
CAG	NULL
GTG	NULL
TTT	NULL
CTT	NULL
CCG	NULL
GAT	NULL
AGC	NULL
ACT	NULL
G	NULL
,	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
2	NULL
ATC	NULL
GGG	NULL
CCC	NULL
CTA	NULL
GAG	NULL
CTT	NULL
CTG	NULL
ACG	NULL
TTT	NULL
CCT	NULL
C	NULL
;	NULL
for	NULL
p50/p65	NULL
chimera	NULL
5	NULL
,	NULL
5	NULL
``	NULL
primer	NULL
1	NULL
GGG	NULL
CCG	NULL
CTC	NULL
GAG	NULL
CTG	NULL
CCA	NULL
ACA	NULL
GCA	NULL
GAT	NULL
GGC	NULL
,	NULL
3	NULL
'	NULL
primer	NULL
1	NULL
CTC	NULL
ACT	NULL
GAG	NULL
CTC	NULL
CCG	NULL
GTC	NULL
GGA	NULL
AGG	NULL
CCT	NULL
CCG	NULL
AAG	NULL
CTG	NULL
GAC	NULL
AAA	NULL
CAC	NULL
,	NULL
5	NULL
primer	NULL
2	NULL
GTG	NULL
TTT	NULL
GTC	NULL
CAG	NULL
CTT	NULL
CGG	NULL
AGG	NULL
CCT	NULL
TCC	NULL
GAC	NULL
CGG	NULL
GAG	NULL
CTC	NULL
AGT	NULL
GAG	NULL
,	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
2	NULL
GTG	NULL
CTC	NULL
TAG	NULL
ACT	NULL
ATG	NULL
TCC	NULL
TTT	NULL
TAC	NULL
GTT	NULL
TCT	NULL
CCT	NULL
CAA	NULL
TC	NULL
;	NULL
for	NULL
p65/p30	NULL
chimera	NULL
6	NULL
,	NULL
5°	NULL
primer	NULL
1	NULL
GGG	NULL
CCG	NULL
CTC	NULL
GAG	NULL
GAG	NULL
CCA	NULL
GCC	NULL
CAG	NULL
GCC	NULL
TCT	NULL
G	NULL
,	NULL
3	NULL
primer	NULL
1	NULL
CCT	NULL
CCG	NULL
AAG	NULL
CTG	NULL
GAC	NULL
AAA	NULL
CAC	NULL
CTC	NULL
ACT	NULL
GAG	NULL
CTC	NULL
CCG	NULL
GTC	NULL
GGA	NULL
AGG	NULL
,	NULL
5°	NULL
primer	NULL
2	NULL
CCT	NULL
TCC	NULL
GAC	NULL
CGG	NULL
GAG	NULL
CTC	NULL
AGT	NULL
GAG	NULL
GTG	NULL
TTT	NULL
GTC	NULL
CAG	NULL
CIT	NULL
CGG	NULL
AGG	NULL
,	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
2	NULL
ATC	NULL
GGG	NULL
CCC	NULL
CTA	NULL
GAG	NULL
CTT	NULL
CTG	NULL
ACG	NULL
TTT	NULL
CCT	NULL
C	NULL
;	NULL
for	NULL
p50	NULL
rel/p65	NULL
chimera	NULL
,	NULL
5°	NULL
primer	NULL
1	NULL
CCG	NULL
CTC	NULL
GAG	NULL
ATG	NULL
GAC	NULL
GAA	NULL
CTG	NULL
TTC	NULL
CCC	NULL
CTC	NULL
ATC	NULL
TTC	NULL
CCG	NULL
GCA	NULL
CTG	NULL
CCA	NULL
ACA	NULL
GCA	NULL
GAT	NULL
GGC	NULL
CC	NULL
,	NULL
3	NULL
'	NULL
primer	NULL
1	NULL
CAT	NULL
GAT	NULL
GCT	NULL
CTT	NULL
GAA	NULL
GGT	NULL
CTC	NULL
ATA	NULL
GAG	NULL
CTT	NULL
CTG	NULL
ACG	NULL
TTT	NULL
CCT	NULL
C	NULL
,	NULL
5	NULL
``	NULL
primer	NULL
2	NULL
G	NULL
AGG	NULL
AAA	NULL
CGT	NULL
CAG	NULL
AAG	NULL
CTC	NULL
TAT	NULL
GAG	NULL
ACC	NULL
TTC	NULL
AAG	NULL
AGC	NULL
ATC	NULL
ATG	NULL
,	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
2	NULL
GTG	NULL
CTC	NULL
TAG	NULL
ATT	NULL
AGG	NULL
AGC	NULL
TGA	NULL
TCT	NULL
GAC	NULL
TCA	NULL
GCA	NULL
G.	NULL
The	NULL
products	NULL
of	NULL
the	NULL
second	NULL
PCR	NULL
reactions	NULL
for	NULL
p50/p65	NULL
chimera	NULL
1	NULL
,	NULL
p50/p65	NULL
chimera	NULL
5	NULL
,	NULL
and	NULL
p50	NULL
rel/p65	NULL
chimera	NULL
were	NULL
digested	NULL
with	NULL
XhoI	NULL
and	NULL
Xbal	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
Xhol-Xbal	NULL
sites	NULL
of	NULL
pcDNA3HA	NULL
.	NULL

The	NULL
products	NULL
of	NULL
the	NULL
second	NULL
PCR	NULL
reactions	NULL
for	NULL
p65/p350	NULL
chimera	NULL
3	NULL
and	NULL
p65/p50	NULL
chimera	NULL
6	NULL
were	NULL
digested	NULL
with	NULL
XhoI	NULL
and	NULL
Apal	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
Xhol-Apal	NULL
sites	NULL
of	NULL
peDNA3HA	NULL
.	NULL

The	NULL
pGEX-Elf-1	NULL
plasmid	NULL
encoding	NULL
a	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-Elf-1	NULL
fusion	NULL
protein	NULL
was	NULL
described	NULL
previously	NULL
(	NULL
103	NULL
)	NULL
.	NULL

The	NULL
pGEX-NFATc	NULL
plasmid	NULL
contains	NULL
the	NULL
full-length	NULL
NFAT	NULL
cDNA	NULL
(	NULL
described	NULL
above	NULL
)	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
the	NULL
pGEX	NULL
plasmid	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

The	NULL
HIV-1	NULL
Luc	NULL
plasmid	NULL
contains	NULL
the	NULL
XAo1-HindIlI	NULL
fragment	NULL
from	NULL
HIV-1	NULL
CAT	NULL
(	NULL
71	NULL
)	NULL
,	NULL
containing	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
,	NULL
cloned	NULL
into	NULL
the	NULL
Xhol	NULL
and	NULL
HindIII	NULL
sites	NULL
of	NULL
pGL2	NULL
basic	NULL
vector	NULL
(	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
.	NULL

The	NULL
pBS	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
HIV-2	NULL
,	NULL
pBS	NULL
HIV-2	NULL
m	NULL
«	NULL
B	NULL
,	NULL
and	NULL
pBS	NULL
HIV-2	NULL
mEts	NULL
constructs	NULL
were	NULL
prepared	NULL
by	NULL
PCR	NULL
using	NULL
as	NULL
templates	NULL
the	NULL
previously	NULL
described	NULL
HIV-2	NULL
CAT	NULL
,	NULL
HIV-2	NULL
m	NULL
«	NULL
BCAT	NULL
,	NULL
and	NULL
HIV-2	NULL
mPUB2	NULL
CAT	NULL
plasmids	NULL
(	NULL
52	NULL
)	NULL
with	NULL
the	NULL
following	NULL
synthetic	NULL
oligonucleotide	NULL
primers	NULL
:	NULL
5	NULL
``	NULL
primer	NULL
CGC	NULL
GGA	NULL
TCC	NULL
AAT	NULL
ACC	NULL
ATT	NULL
TAG	NULL
TTA	NULL
AAG	NULL
and	NULL
3	NULL
'	NULL
primer	NULL
CGC	NULL
GGA	NULL
TCC	NULL
GGT	NULL
TAC	NULL
AGC	NULL
CCC	NULL
TTC	NULL
TGG	NULL
.	NULL

The	NULL
products	NULL
of	NULL
these	NULL
PCR	NULL
reactions	NULL
were	NULL
digested	NULL
with	NULL
BemHI	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
sites	NULL
of	NULL
pBS	NULL
KS~	NULL
(	NULL
Stratagene	NULL
Corp.	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

HIV-2wtLuc	NULL
,	NULL
HIV-2m	NULL
«	NULL
BLuc	NULL
,	NULL
and	NULL
HIV-2mEtsLuc	NULL
were	NULL
constructed	NULL
by	NULL
cloning	NULL
the	NULL
HIV-2	NULL
promoter/enhancers	NULL
from	NULL
HIV-2	NULL
CAT	NULL
,	NULL
HIV-2	NULL
m	NULL
«	NULL
BCAT	NULL
,	NULL
and	NULL
HIV-2	NULL
Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
mPUB2	NULL
CAT	NULL
plasmids	NULL
(	NULL
52	NULL
)	NULL
into	NULL
the	NULL
St1-HindIII	NULL
sites	NULL
of	NULL
the	NULL
pGL2	NULL
basic	NULL
vector	NULL
.	NULL

The	NULL
identities	NULL
of	NULL
all	NULL
constructs	NULL
made	NULL
by	NULL
using	NULL
PCR	NULL
were	NULL
confirmed	NULL
by	NULL
dideoxy	NULL
DNA	NULL
sequence	NULL
analysis	NULL
.	NULL

Antibodies	NULL
.	NULL

The	NULL
«	NULL
-Myc	NULL
,	NULL
a-Myb	NULL
,	NULL
and	NULL
a-p50	NULL
polyclonal	NULL
antibodies	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
a-NFAT	NULL
antibody	NULL
was	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
Inc.	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
N.Y.	NULL
)	NULL
.	NULL

The	NULL
a-Elf-1	NULL
polyclonal	NULL
antibody	NULL
and	NULL
the	NULL
6G7	NULL
(	NULL
101	NULL
)	NULL
«	NULL
-Elf-1	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MAb	NULL
)	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
3	NULL
)	NULL
.	NULL

EMSAs	NULL
.	NULL

A	NULL
double-stranded	NULL
oligonucleotide	NULL
derived	NULL
from	NULL
the	NULL
HIV-2	NULL
LTR	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
CAGCTGAGACTGCAGGGACTTTCCAGAAGGGGCTG	NULL
)	NULL
(	NULL
52	NULL
)	NULL
and	NULL
containing	NULL
overhanging	NULL
BeamHI-Bgill	NULL
ends	NULL
was	NULL
labeled	NULL
with	NULL
*°P	NULL
nucleotides	NULL
by	NULL
using	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
and	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
101	NULL
)	NULL
.	NULL

For	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
using	NULL
either	NULL
wild-type	NULL
or	NULL
mutant	NULL
versions	NULL
of	NULL
the	NULL
-186	NULL
to	NULL
-83	NULL
region	NULL
from	NULL
the	NULL
HIV-2	NULL
LTR	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
the	NULL
BamHI	NULL
fragments	NULL
from	NULL
either	NULL
pBS	NULL
HIV-2	NULL
wt	NULL
oligo	NULL
,	NULL
pBS	NULL
HIV-2	NULL
m	NULL
«	NULL
B	NULL
oligo	NULL
,	NULL
or	NULL
pBS	NULL
HIV-2	NULL
mEts	NULL
oligo	NULL
were	NULL
excised	NULL
,	NULL
gel	NULL
purified	NULL
,	NULL
and	NULL
labeled	NULL
with	NULL
*°P	NULL
nucleotides	NULL
by	NULL
using	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
as	NULL
described	NULL
above	NULL
.	NULL

For	NULL
supershift	NULL
experiments	NULL
,	NULL
1	NULL
pl	NULL
of	NULL
the	NULL
«	NULL
-CREM	NULL
,	NULL
«	NULL
-p50	NULL
,	NULL
or	NULL
a-Elf-1	NULL
polyclonal	NULL
antibody	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reactions	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
reactions	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
system	NULL
,	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
104	NULL
)	NULL
.	NULL

GST	NULL
fusion	NULL
proteins	NULL
and	NULL
binding	NULL
assays	NULL
.	NULL

Glutathione-Sepahrose	NULL
beads	NULL
(	NULL
Pharmacia	NULL
)	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
NETN	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
plus	NULL
0.5	NULL
%	NULL
powdered	NULL
milk	NULL
.	NULL

Preparations	NULL
of	NULL
S-labeled	NULL
in	NULL
vitro-translated	NULL
NF-xB/NFAT	NULL
and	NULL
Ets	NULL
proteins	NULL
were	NULL
precleared	NULL
by	NULL
incubation	NULL
with	NULL
30	NULL
pl	NULL
of	NULL
glutathione-Sepharose	NULL
beads	NULL
(	NULL
Pharmacia	NULL
)	NULL
in	NULL
500	NULL
pl	NULL
of	NULL
NETN	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Overnight	NULL
cultures	NULL
of	NULL
Escherichia	NULL
coli	NULL
DHS	NULL
«	NULL
containing	NULL
either	NULL
the	NULL
pGEX-3X	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
pGEX-Elf-1	NULL
,	NULL
or	NULL
pGEX-NFATc	NULL
plasmid	NULL
were	NULL
diluted	NULL
1:10	NULL
in	NULL
Luria	NULL
broth	NULL
and	NULL
grown	NULL
for	NULL
1	NULL
h	NULL
with	NULL
shaking	NULL
at	NULL
37°C	NULL
.	NULL

Isopropyl-B-p-thiogalactopyranoside	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.1	NULL
mM	NULL
,	NULL
and	NULL
cultures	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
4	NULL
h	NULL
with	NULL
shaking	NULL
.	NULL

Bacteria	NULL
were	NULL
pelleted	NULL
and	NULL
resuspended	NULL
in	NULL
NETN	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
sonicated	NULL
three	NULL
times	NULL
for	NULL
15	NULL
s	NULL
each	NULL
time	NULL
on	NULL
ice	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
GST	NULL
fusion	NULL
proteins	NULL
(	NULL
as	NULL
determined	NULL
by	NULL
Coomassie	NULL
blue	NULL
staining	NULL
)	NULL
were	NULL
bound	NULL
to	NULL
30	NULL
pl	NULL
of	NULL
glutathione-Sepharose	NULL
beads	NULL
by	NULL
incubation	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
1	NULL
ml	NULL
of	NULL
NETN	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
NETN	NULL
and	NULL
mixed	NULL
with	NULL
equivalent	NULL
molar	NULL
amounts	NULL
(	NULL
as	NULL
determined	NULL
by	NULL
phosphorimager	NULL
analysis	NULL
)	NULL
of	NULL
pre-cleared	NULL
,	NULL
*°S-labeled	NULL
,	NULL
in	NULL
vitro-translated	NULL
proteins	NULL
at	NULL
4°C	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
beads	NULL
were	NULL
incubated	NULL
with	NULL
NETN	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
were	NULL
eluted	NULL
by	NULL
boiling	NULL
for	NULL
3	NULL
min	NULL
in	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
loading	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
6.8	NULL
]	NULL
,	NULL
30	NULL
%	NULL
glycerol	NULL
,	NULL
0.4	NULL
%	NULL
SDS	NULL
,	NULL
0.1	NULL
%	NULL
bromophenol	NULL
blue	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
B-mercaptocthanol	NULL
.	NULL

For	NULL
the	NULL
ethidium	NULL
bromide	NULL
(	NULL
EtBr	NULL
)	NULL
experiments	NULL
,	NULL
beads	NULL
were	NULL
incubated	NULL
with	NULL
NETN	NULL
containing	NULL
either	NULL
10	NULL
or	NULL
100	NULL
ug	NULL
of	NULL
EtBr	NULL
per	NULL
ml	NULL
.	NULL

For	NULL
the	NULL
propidium	NULL
iodide	NULL
(	NULL
PT	NULL
)	NULL
experiments	NULL
,	NULL
beads	NULL
were	NULL
incubated	NULL
with	NULL
NETN	NULL
containing	NULL
either	NULL
7.5	NULL
or	NULL
15	NULL
g	NULL
of	NULL
PI	NULL
per	NULL
ml	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Isolation	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
lym-phocytes	NULL
were	NULL
isolated	NULL
from	NULL
buffy	NULL
coat	NULL
cells	NULL
obtained	NULL
by	NULL
leukapheresis	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
isolated	NULL
with	NULL
a	NULL
commercially	NULL
available	NULL
column	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Research	NULL
and	NULL
Development	NULL
Systems	NULL
,	NULL
Boulder	NULL
,	NULL
Colo.	NULL
)	NULL
.	NULL

Cells	NULL
purified	NULL
by	NULL
this	NULL
method	NULL
are	NULL
>	NULL
98	NULL
%	NULL
T	NULL
cells	NULL
as	NULL
determined	NULL
by	NULL
fluorescence-acti-vated	NULL
cell	NULL
sorting	NULL
analysis	NULL
with	NULL
an	NULL
«	NULL
-CD3	NULL
MAb	NULL
.	NULL

Purified	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
x	NULL
10	NULL
%	NULL
/ml	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
GIBCO	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
N.Y.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
GIBCO	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
100	NULL
U	NULL
of	NULL
penicillin	NULL
G	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
15	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
(	NULL
GIBCO	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
activated	NULL
by	NULL
treatment	NULL
for	NULL
8	NULL
h	NULL
with	NULL
phorbal	NULL
myristate	NULL
acetate	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
plus	NULL
ionomycin	NULL
(	NULL
0.4	NULL
pg/ml	NULL
)	NULL
.	NULL

Immunoprecipitations	NULL
.	NULL

Activated	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
0.5	NULL
X	NULL
10°	NULL
to	NULL
1	NULL
X	NULL
10°	NULL
)	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
ice-cold	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
lysed	NULL
by	NULL
incubation	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
NETN	NULL
plus	NULL
protease	NULL
inhibitors	NULL
(	NULL
0.1	NULL
mM	NULL
aprotinin	NULL
,	NULL
1	NULL
mM	NULL
leupeptin	NULL
,	NULL
and	NULL
0.1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
in	NULL
a	NULL
microcentrifuge	NULL
at	NULL
16,000	NULL
x	NULL
g	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Cell	NULL
extract	NULL
(	NULL
1	NULL
ml	NULL
)	NULL
was	NULL
mixed	NULL
with	NULL
10	NULL
pl	NULL
of	NULL
«	NULL
-CREM	NULL
,	NULL
«	NULL
-Myc	NULL
,	NULL
«	NULL
-Myb	NULL
,	NULL
and	NULL
a-p350	NULL
or	NULL
a-NFAT	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Protein	NULL
A-Sepharose	NULL
(	NULL
50	NULL
wl	NULL
)	NULL
was	NULL
added	NULL
to	NULL
each	NULL
immunoprecipitation	NULL
reaction	NULL
mixture	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
five	NULL
times	NULL
with	NULL
NETN	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
were	NULL
eluted	NULL
by	NULL
boiling	NULL
in	NULL
SDS-PAGE	NULL
loading	NULL
buffer	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
in	NULL
SDS-8	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Immunoblots	NULL
were	NULL
probed	NULL
with	NULL
a	NULL
1:500	NULL
dilution	NULL
of	NULL
the	NULL
«	NULL
-Elf-1	NULL
MAb	NULL
6G7	NULL
in	NULL
conjunction	NULL
with	NULL
a	NULL
1:3,000	NULL
dilution	NULL
of	NULL
a	NULL
commercially	NULL
available	NULL
horseradish	NULL
peroxidase-coupled	NULL
goat	NULL
antibody	NULL
to	NULL
mouse	NULL
immunoglobulin	NULL
(	NULL
GIBCO	NULL
)	NULL
.	NULL

Immunoblots	NULL
were	NULL
developed	NULL
by	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IIL	NULL
.	NULL
)	NULL

as	NULL
described	NULL
previously	NULL
(	NULL
103	NULL
)	NULL
.	NULL

Transfections	NULL
and	NULL
luciferase	NULL
assays	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
with	NULL
4.5	NULL
g	NULL
of	NULL
glucose	NULL
per	NULL
liter	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
penicillin-streptomycin	NULL
(	NULL
GIBCO	NULL
)	NULL
.	NULL

Exponentially	NULL
growing	NULL
cultures	NULL
containing	NULL
6	NULL
X	NULL
10°	NULL
COS	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
the	NULL
HIV-1	NULL
Luc	NULL
reporter	NULL
plasmid	NULL
and	NULL
various	NULL
amounts	NULL
of	NULL
Ets-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
eukaryotic	NULL
expression	NULL
plasmids	NULL
by	NULL
using	NULL
Lipofectamine	NULL
reagent	NULL
(	NULL
GIBCO	NULL
)	NULL
ac	NULL
Ets-NF-	NULL
«	NULL
B/NFAT	NULL
PHYSICAL	NULL
INTERACTION	NULL
_	NULL
3565	NULL
A	NULL
o	NULL
o.	NULL
E	NULL
i	NULL
&	NULL
&	NULL
g	NULL
8	NULL
27	NULL
o	NULL
o	NULL
NFATp	NULL
97	NULL
-	NULL
%	NULL
«	NULL
**	NULL
___	NULL
inFatec	NULL
7Tp65	NULL
46	NULL
-	NULL
a	NULL
=	NULL
-	NULL
p50	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
80	NULL
9	NULL
101112	NULL
IVT	NULL
PU.1	NULL
IVT	NULL
EHf-1	NULL
-Elf-1	NULL
-PU.1	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Physical	NULL
association	NULL
between	NULL
Elf-1	NULL
and	NULL
NFATc	NULL
,	NULL
NFATp	NULL
,	NULL
and	NULL
p50	NULL
.	NULL

Equivalent	NULL
molar	NULL
amounts	NULL
of	NULL
*°S-labeled	NULL
in	NULL
vitro-translated	NULL
(	NULL
IVT	NULL
)	NULL
NFAT	NULL
,	NULL
NFATp	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
p65	NULL
proteins	NULL
were	NULL
mixed	NULL
with	NULL
1	NULL
mg	NULL
of	NULL
bacterially	NULL
expressed	NULL
GST-Elf-1	NULL
or	NULL
an	NULL
equivalent	NULL
amount	NULL
of	NULL
the	NULL
GST	NULL
control	NULL
protein	NULL
.	NULL

The	NULL
protein	NULL
complexes	NULL
were	NULL
denatured	NULL
and	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
prior	NULL
to	NULL
autoradiogra-phy	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Association	NULL
of	NULL
Elf-1	NULL
and	NULL
PU.1	NULL
with	NULL
NFATe	NULL
.	NULL

Equivalent	NULL
molar	NULL
amounts	NULL
of	NULL
*°S-labeled	NULL
in	NULL
vitro-translated	NULL
Elf-1	NULL
and	NULL
PU.1	NULL
were	NULL
mixed	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
bacterially	NULL
expressed	NULL
GST-NFAT	NULL
or	NULL
an	NULL
equivalent	NULL
amount	NULL
of	NULL
the	NULL
GST	NULL
control	NULL
protein	NULL
.	NULL

*°S-labeled	NULL
in	NULL
vitro-translated	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
proteins	NULL
were	NULL
run	NULL
directly	NULL
in	NULL
parallel	NULL
on	NULL
the	NULL
same	NULL
gel	NULL
.	NULL

The	NULL
resulting	NULL
complexes	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
.	NULL

Size	NULL
markers	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
are	NULL
shown	NULL
to	NULL
the	NULL
left	NULL
of	NULL
each	NULL
autoradiogram	NULL
.	NULL

cording	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Each	NULL
transfection	NULL
mixture	NULL
contained	NULL
a	NULL
total	NULL
of	NULL
21	NULL
g	NULL
of	NULL
DNA	NULL
including	NULL
1	NULL
pg	NULL
of	NULL
the	NULL
RSV-B-galactosidase	NULL
reference	NULL
plasmid	NULL
and	NULL
57	NULL
pl	NULL
of	NULL
Lipofectamine	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
prepared	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
normalized	NULL
for	NULL
protein	NULL
content	NULL
by	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
101	NULL
)	NULL
.	NULL

RESULTS	NULL
A	NULL
physical	NULL
interaction	NULL
between	NULL
Ets	NULL
and	NULL
NF-KB/NFAT	NULL
transcription	NULL
factors	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
functionally	NULL
important	NULL
and	NULL
adjacent	NULL
(	NULL
and/or	NULL
overlapping	NULL
)	NULL
binding	NULL
sites	NULL
for	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
kB/NFAT	NULL
transcription	NULL
factors	NULL
in	NULL
multiple	NULL
inducible	NULL
lymphoid	NULL
genes	NULL
,	NULL
including	NULL
those	NULL
for	NULL
human	NULL
IL-2	NULL
(	NULL
15	NULL
,	NULL
42	NULL
,	NULL
87	NULL
)	NULL
,	NULL
IL-3	NULL
(	NULL
18	NULL
,	NULL
19	NULL
,	NULL
28	NULL
)	NULL
,	NULL
IL-2	NULL
receptor	NULL
alpha	NULL
(	NULL
44	NULL
,	NULL
54	NULL
,	NULL
95	NULL
)	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
(	NULL
18	NULL
,	NULL
66	NULL
,	NULL
87	NULL
,	NULL
101	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
viral	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
including	NULL
the	NULL
HIV-1	NULL
and	NULL
HIV-2	NULL
enhancers	NULL
(	NULL
38	NULL
,	NULL
52	NULL
,	NULL
71	NULL
,	NULL
77	NULL
,	NULL
89	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
kB/NFAT	NULL
proteins	NULL
can	NULL
associate	NULL
in	NULL
vitro	NULL
,	NULL
full-length	NULL
recombinant	NULL
bacterial	NULL
GST-EIf-1	NULL
fusion	NULL
protein	NULL
was	NULL
incubated	NULL
with	NULL
equivalent	NULL
molar	NULL
amounts	NULL
of	NULL
3°S-labeled	NULL
in	NULL
vitro-translated	NULL
NFATc	NULL
,	NULL
NFATp	NULL
,	NULL
p50	NULL
,	NULL
or	NULL
p65	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

NFATe	NULL
,	NULL
NFATp	NULL
,	NULL
and	NULL
p50	NULL
each	NULL
associated	NULL
efficiently	NULL
with	NULL
GST-Elf-1	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
associations	NULL
between	NULL
GST-EIf-1	NULL
and	NULL
NFAT	NULL
c	NULL
,	NULL
NFAT	NULL
p	NULL
,	NULL
and	NULL
p50	NULL
were	NULL
specific	NULL
because	NULL
none	NULL
of	NULL
these	NULL
proteins	NULL
associated	NULL
with	NULL
GST	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
)	NULL
and	NULL
because	NULL
GST-Elf-1	NULL
did	NULL
not	NULL
associate	NULL
with	NULL
the	NULL
structurally	NULL
related	NULL
NF-kB	NULL
family	NULL
member	NULL
p65	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

In	NULL
reciprocal	NULL
experiments	NULL
,	NULL
full	NULL
3566	NULL
BASSUK	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
ViRoL	NULL
.	NULL

A	NULL
NFATe	NULL
Association	NULL
B	NULL
F.	NULL
A	NULL
2	NULL
Activation	NULL
Ets	NULL
g	NULL
g	NULL
E	NULL
ﬂ	NULL
?	NULL

t	NULL
--	NULL
-	NULL
Ser/Thr	NULL
ATe	NULL
+	NULL
+	NULL
a	NULL
3	NULL
9	NULL
Elf-1	NULL
l	NULL
|	NULL
II	NULL
L	NULL
|	NULL
1	NULL
]	NULL
+	NULL
Elf-1	NULL
19	NULL
|	NULL
+	NULL
55	NULL
p	NULL
1	NULL
1	NULL
-	NULL
&	NULL
&	NULL
1	NULL
100	NULL
209	NULL
288	NULL
619	NULL
Elf-1	NULL
I	NULL
;	NULL
I	NULL
;	NULL
u	NULL
Ets-1	NULL
+	NULL
C	NULL
Elf-1290-619	NULL
K	NULL
hund	NULL
iol	NULL
lox	NULL
«	NULL
-	NULL
-Elf-1299-619	NULL
Elf-1196-295	NULL
{	NULL
Oud	NULL
+	NULL
g	NULL
l	NULL
a	NULL
Activation	NULL
LL	NULL
E	NULL
Ets-1	NULL
|	NULL
|	NULL
[	NULL
T__	NULL
|	NULL
|	NULL
|	NULL
]	NULL
+	NULL
I	NULL
I	NULL
1	NULL
I	NULL
1	NULL
133	NULL
331	NULL
415	NULL
Bis	NULL
}	NULL
w	NULL
<	NULL
>	NULL
14.5	NULL
-	NULL
§	NULL
WIP	NULL
-Ets-1331.418	NULL
Ets-1331-418	NULL
m	NULL
|	NULL
+	NULL
1	NULL
2	NULL
30	NULL
4	NULL
50	NULL
6	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
illustration	NULL
of	NULL
full-length	NULL
and	NULL
truncated	NULL
Elf-1	NULL
and	NULL
Ets-1	NULL
proteins	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
Ets	NULL
domains	NULL
of	NULL
Elf-1	NULL
and	NULL
Ets-1	NULL
(	NULL
ETS	NULL
)	NULL
(	NULL
96	NULL
)	NULL
,	NULL
the	NULL
transcriptional	NULL
transactivation	NULL
domains	NULL
of	NULL
Ets-1	NULL
and	NULL
Elf-1	NULL
(	NULL
Activation	NULL
)	NULL
(	NULL
103	NULL
)	NULL
,	NULL
the	NULL
Rb	NULL
binding	NULL
domain	NULL
of	NULL
Elf-1	NULL
(	NULL
Rb	NULL
)	NULL
(	NULL
103	NULL
)	NULL
,	NULL
the	NULL
serine-	NULL
and	NULL
threonine-rich	NULL
region	NULL
of	NULL
Elf-1	NULL
(	NULL
Ser/Thr	NULL
)	NULL
(	NULL
96	NULL
)	NULL
,	NULL
and	NULL
the	NULL
inhibitory	NULL
domains	NULL
of	NULL
Ets-1	NULL
(	NULL
Inhib	NULL
.	NULL
)	NULL

(	NULL
30	NULL
,	NULL
31	NULL
,	NULL
45	NULL
,	NULL
56	NULL
,	NULL
78	NULL
,	NULL
106	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

Amino	NULL
acid	NULL
numbers	NULL
are	NULL
shown	NULL
below	NULL
the	NULL
schematic	NULL
illustrations	NULL
of	NULL
the	NULL
full-length	NULL
Elf-1	NULL
and	NULL
Ets-1	NULL
proteins	NULL
.	NULL

Binding	NULL
(	NULL
+	NULL
)	NULL
or	NULL
lack	NULL
of	NULL
binding	NULL
(	NULL
-	NULL
)	NULL
to	NULL
GST-NFATc	NULL
is	NULL
indicated	NULL
under	NULL
NFATe	NULL
Association	NULL
.	NULL

(	NULL
B	NULL
)	NULL
NFAT	NULL
interacts	NULL
with	NULL
the	NULL
Ets	NULL
domains	NULL
of	NULL
Elf-1	NULL
and	NULL
Ets-1	NULL
.	NULL

*S-labeled	NULL
in	NULL
vitro-translated	NULL
Ets	NULL
proteins	NULL
shown	NULL
in	NULL
panel	NULL
A	NULL
were	NULL
mixed	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
GST-NFATc	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

S-labeled	NULL
in	NULL
vitro-translated	NULL
(	NULL
IVT	NULL
)	NULL
Ets	NULL
proteins	NULL
were	NULL
run	NULL
directly	NULL
in	NULL
parallel	NULL
on	NULL
the	NULL
same	NULL
ge	NULL
!	NULL

(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

Size	NULL
markers	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
are	NULL
shown	NULL
to	NULL
the	NULL
left	NULL
of	NULL
the	NULL
autoradiogram	NULL
.	NULL

length	NULL
recombinant	NULL
bacterial	NULL
GST-NFATc	NULL
fusion	NULL
protein	NULL
was	NULL
incubated	NULL
with	NULL
equivalent	NULL
molar	NULL
amounts	NULL
of	NULL
*°S-labeled	NULL
in	NULL
vitro-translated	NULL
Ets-related	NULL
proteins	NULL
Elf-1	NULL
and	NULL
PU.1	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Both	NULL
Elf-1	NULL
and	NULL
PU.1	NULL
associated	NULL
specifically	NULL
and	NULL
efficiently	NULL
with	NULL
GST-NFATc	NULL
but	NULL
not	NULL
with	NULL
GST	NULL
alone	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
experiments	NULL
demonstrated	NULL
that	NULL
the	NULL
distantly	NULL
related	NULL
Ets	NULL
proteins	NULL
Elf-1	NULL
and	NULL
PU.1	NULL
are	NULL
capable	NULL
of	NULL
associating	NULL
with	NULL
several	NULL
related	NULL
but	NULL
evolutionarily	NULL
divergent	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
proteins	NULL
,	NULL
including	NULL
NFATe	NULL
,	NULL
NFAT	NULL
p	NULL
,	NULL
and	NULL
p50	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Elf-1	NULL
does	NULL
not	NULL
associate	NULL
with	NULL
p65	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
Ets	NULL
domain	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
the	NULL
association	NULL
of	NULL
Ets	NULL
and	NULL
proteins	NULL
.	NULL

The	NULL
82-aa	NULL
Ets	NULL
domain	NULL
is	NULL
highly	NULL
conserved	NULL
between	NULL
all	NULL
Ets	NULL
family	NULL
members	NULL
(	NULL
47	NULL
,	NULL
105	NULL
)	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
our	NULL
finding	NULL
that	NULL
the	NULL
distantly	NULL
related	NULL
Ets	NULL
family	NULL
members	NULL
Elf-1	NULL
and	NULL
PU.1	NULL
both	NULL
associated	NULL
efficiently	NULL
with	NULL
NFATc	NULL
suggested	NULL
that	NULL
the	NULL
association	NULL
between	NULL
Ets	NULL
and	NULL
NF-kB/NFAT	NULL
proteins	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
Ets	NULL
domain	NULL
of	NULL
the	NULL
Ets	NULL
proteins	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
directly	NULL
,	NULL
GST-NFATe	NULL
was	NULL
mixed	NULL
with	NULL
different	NULL
deletion	NULL
mutants	NULL
of	NULL
*°S-labeled	NULL
in	NULL
vitro-translated	NULL
Ets	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
isolated	NULL
Ets	NULL
domain	NULL
of	NULL
Elf-1	NULL
(	NULL
Elf-1195	NULL
705	NULL
)	NULL
and	NULL
the	NULL
Ets	NULL
domain	NULL
of	NULL
Ets-1	NULL
(	NULL
Ets-1331	NULL
4183	NULL
)	NULL
each	NULL
efficiently	NULL
associated	NULL
with	NULL
GST-NFATc	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
deletion	NULL
mutant	NULL
of	NULL
Elf-1	NULL
lacking	NULL
the	NULL
Ets	NULL
domain	NULL
(	NULL
Elf-159	NULL
)	NULL
419	NULL
)	NULL
failed	NULL
to	NULL
associate	NULL
with	NULL
NFATc	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
experiments	NULL
demonstrated	NULL
that	NULL
the	NULL
Ets	NULL
domain	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
the	NULL
interaction	NULL
of	NULL
Ets	NULL
transcription	NULL
factors	NULL
with	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
proteins	NULL
.	NULL

The	NULL
Rel	NULL
HDs	NULL
of	NULL
specific	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
proteins	NULL
are	NULL
sufficient	NULL
to	NULL
mediate	NULL
their	NULL
interactions	NULL
with	NULL
Ets	NULL
proteins	NULL
.	NULL

Having	NULL
established	NULL
that	NULL
the	NULL
Ets	NULL
domains	NULL
of	NULL
Ets	NULL
transcription	NULL
factors	NULL
are	NULL
required	NULL
for	NULL
their	NULL
interactions	NULL
with	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
,	NULL
we	NULL
attempted	NULL
to	NULL
map	NULL
the	NULL
region	NULL
(	NULL
s	NULL
)	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kB/NFAT	NULL
proteins	NULL
that	NULL
is	NULL
required	NULL
for	NULL
their	NULL
interactions	NULL
with	NULL
Ets	NULL
proteins	NULL
.	NULL

°°S-labeled	NULL
in	NULL
vitro-translated	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
NF-kB/	NULL
NFAT	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
were	NULL
analyzed	NULL
for	NULL
their	NULL
abilities	NULL
to	NULL
associate	NULL
with	NULL
GST-Elf-1	NULL
.	NULL

Full-length	NULL
NFATe	NULL
and	NULL
NFATp	NULL
both	NULL
associated	NULL
efficiently	NULL
with	NULL
GST-Elf-1	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
,	NULL
as	NULL
did	NULL
deletion	NULL
mutants	NULL
containing	NULL
only	NULL
the	NULL
Rel	NULL
HDs	NULL
of	NULL
NFATe	NULL
(	NULL
NFATcq153-716	NULL
)	NULL
,	NULL
NFATp	NULL
(	NULL
NFATP1_520	NULL
)	NULL
,	NULL
P50	NULL
367	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
c-Rel	NULL
;	NULL
;	NULL
55	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
)	NULL
.	NULL

In	NULL
con	NULL
trast	NULL
,	NULL
deletion	NULL
mutants	NULL
lacking	NULL
the	NULL
Rel	NULL
HD	NULL
of	NULL
NFATce	NULL
(	NULL
NFATe	NULL
,	NULL
,	NULL
,	NULL
,	NULL
)	NULL
or	NULL
NFATp	NULL
(	NULL
NFATpPs	NULL
»	NULL
,	NULL
soo	NULL
)	NULL
failed	NULL
to	NULL
associate	NULL
with	NULL
GST-Elf-1	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
.	NULL

In	NULL
reciprocal	NULL
experiments	NULL
using	NULL
different	NULL
mutant	NULL
GST-NF-	NULL
«	NULL
kB/NFAT	NULL
proteins	NULL
(	NULL
including	NULL
NFATc	NULL
,	NULL
NFATp	NULL
,	NULL
and	NULL
p50	NULL
)	NULL
and	NULL
several	NULL
different	NULL
Ets	NULL
proteins	NULL
(	NULL
including	NULL
Elf-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
PU.1	NULL
)	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
Rel	NULL
HDs	NULL
were	NULL
uniformly	NULL
required	NULL
for	NULL
the	NULL
interaction	NULL
between	NULL
each	NULL
of	NULL
the	NULL
and	NULL
Ets	NULL
proteins	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
experiments	NULL
demonstrated	NULL
that	NULL
the	NULL
Rel	NULL
HDs	NULL
of	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
proteins	NULL
are	NULL
both	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
their	NULL
association	NULL
with	NULL
Ets	NULL
family	NULL
members	NULL
.	NULL

Fine	NULL
mapping	NULL
of	NULL
the	NULL
Ets	NULL
interaction	NULL
domain	NULL
of	NULL
p50	NULL
.	NULL

The	NULL
p65	NULL
protein	NULL
contains	NULL
a	NULL
Rel	NULL
HD	NULL
that	NULL
is	NULL
more	NULL
related	NULL
to	NULL
the	NULL
Rel	NULL
HD	NULL
of	NULL
p50	NULL
than	NULL
to	NULL
the	NULL
Rel	NULL
HDs	NULL
of	NULL
the	NULL
NFAT	NULL
proteins	NULL
(	NULL
73	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
was	NULL
somewhat	NULL
surprising	NULL
that	NULL
the	NULL
full-length	NULL
p65	NULL
protein	NULL
,	NULL
unlike	NULL
the	NULL
p50	NULL
,	NULL
NFATc	NULL
,	NULL
and	NULL
c-Rel	NULL
proteins	NULL
,	NULL
failed	NULL
to	NULL
bind	NULL
to	NULL
GST-Elf-1	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

There	NULL
were	NULL
at	NULL
least	NULL
two	NULL
possible	NULL
explanations	NULL
for	NULL
this	NULL
finding	NULL
.	NULL

First	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
p65	NULL
protein	NULL
contains	NULL
a	NULL
region	NULL
(	NULL
s	NULL
)	NULL
outside	NULL
of	NULL
the	NULL
Rel	NULL
HD	NULL
which	NULL
inhibits	NULL
the	NULL
interaction	NULL
between	NULL
Elf-1	NULL
and	NULL
p65	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
Rel	NULL
HD	NULL
of	NULL
p65	NULL
may	NULL
lack	NULL
an	NULL
Ets	NULL
binding	NULL
motif	NULL
.	NULL

To	NULL
distinguish	NULL
between	NULL
these	NULL
possibilities	NULL
,	NULL
GST-Elf-1	NULL
was	NULL
incubated	NULL
with	NULL
a	NULL
peptide	NULL
encompassing	NULL
only	NULL
the	NULL
Rel	NULL
HD	NULL
of	NULL
p65	NULL
(	NULL
p65	NULL
;	NULL
,	NULL
_	NULL
304	NULL
)	NULL
.	NULL

Like	NULL
wild-type	NULL
p65	NULL
,	NULL
p651i	NULL
s	NULL
,	NULL
,	NULL
failed	NULL
to	NULL
associate	NULL
with	NULL
GST-Elf-1	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
p65	NULL
does	NULL
not	NULL
contain	NULL
a	NULL
region	NULL
outside	NULL
of	NULL
the	NULL
Rel	NULL
HD	NULL
that	NULL
inhibits	NULL
its	NULL
interaction	NULL
with	NULL
Ets	NULL
proteins	NULL
but	NULL
,	NULL
instead	NULL
,	NULL
lacks	NULL
an	NULL
Ets	NULL
binding	NULL
domain	NULL
.	NULL

To	NULL
map	NULL
more	NULL
finely	NULL
the	NULL
region	NULL
of	NULL
NF-kB/NFAT	NULL
that	NULL
is	NULL
required	NULL
for	NULL
its	NULL
interaction	NULL
with	NULL
Ets	NULL
proteins	NULL
,	NULL
a	NULL
series	NULL
of	NULL
chimeric	NULL
proteins	NULL
containing	NULL
regions	NULL
from	NULL
p50	NULL
and	NULL
p65	NULL
were	NULL
constructed	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

S-labeled	NULL
in	NULL
vitro-translated	NULL
proteins	NULL
produced	NULL
from	NULL
these	NULL
mutants	NULL
were	NULL
assayed	NULL
for	NULL
their	NULL
abilities	NULL
to	NULL
associate	NULL
with	NULL
GST-Elf-1	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Whereas	NULL
chimeras	NULL
containing	NULL
the	NULL
C-terminal	NULL
31	NULL
aa	NULL
from	NULL
the	NULL
Rel	NULL
HD	NULL
of	NULL
p50	NULL
(	NULL
P506	NULL
357	NULL
p65/p50	NULL
chimera	NULL
3	NULL
,	NULL
and	NULL
p65/pS50	NULL
chimera	NULL
6	NULL
)	NULL
each	NULL
associated	NULL
efficiently	NULL
with	NULL
GST-EIf-1	NULL
,	NULL
mutant	NULL
proteins	NULL
lacking	NULL
these	NULL
31	NULL
aa	NULL
but	NULL
containing	NULL
instead	NULL
the	NULL
homologous	NULL
31-aa	NULL
region	NULL
from	NULL
the	NULL
Rel	NULL
HD	NULL
of	NULL
p65	NULL
(	NULL
P65	NULL
;	NULL
3,4	NULL
,	NULL
p50/p65	NULL
chimera	NULL
1	NULL
,	NULL
and	NULL
p50/p65	NULL
chimera	NULL
5	NULL
)	NULL
failed	NULL
to	NULL
associate	NULL
with	NULL
GST-EIf-1	NULL
.	NULL

The	NULL
abilities	NULL
of	NULL
these	NULL
proteins	NULL
to	NULL
interact	NULL
with	NULL
Elf-1	NULL
were	NULL
independent	NULL
of	NULL
their	NULL
Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
A	NULL
ﬂD—ﬁ	NULL
Elf-1	NULL
Association	NULL
s	NULL
+	NULL
1	NULL
418	NULL
Tio	NULL
716	NULL
NFATCq4.q417	NULL
o	NULL
NFATeqi1g-716	NULL
r	NULL
+	NULL
neatp	NULL
--	NULL
-	NULL
-I-1	NULL
228	NULL
520	NULL
890	NULL
NFATP1.520	NULL
C_	NULL
T	NULL
~~	NULL
3	NULL
+	NULL
NFATP521.399	NULL
o	NULL
P503g.367	NULL
o	NULL
+	NULL
36	NULL
367	NULL
o	NULL
+	NULL
i	NULL
295	NULL
PS541-304	NULL
o	NULL
11	NULL
304	NULL
B	NULL
GST-EIf-1	NULL
NFATe	NULL
NFATe	NULL
NFATc	NULL
NFAT	NULL
©	NULL
mo	NULL
R	NULL
o	NULL
g	NULL
=	NULL
«	NULL
g	NULL
=~	NULL
NFAT	NULL
I	NULL
3	NULL
_	NULL
§	NULL
Re	NULL
e	NULL
22	NULL
2	NULL
&	NULL
f	NULL
f	NULL
if	NULL
G	NULL
if	NULL
2	NULL
Z2	NULL
Z	NULL
Z	NULL
2	NULL
2	NULL
P6511-304	NULL
5	NULL
5	NULL
5	NULL
55	NULL
5	NULL
69	NULL
-	NULL
e	NULL
us	NULL
«	NULL
me	NULL
we	NULL
«	NULL
«	NULL
46	NULL
-	NULL
«	NULL
-30	NULL
-	NULL
al	NULL
1	NULL
2	NULL
B	NULL
4	NULL
50	NULL
60	NULL
7	NULL
80	NULL
90	NULL
40	NULL
11	NULL
12	NULL
1391415	NULL
abilities	NULL
to	NULL
bind	NULL
DNA	NULL
,	NULL
since	NULL
all	NULL
of	NULL
the	NULL
mutant	NULL
and	NULL
chimeric	NULL
proteins	NULL
bound	NULL
efficiently	NULL
to	NULL
the	NULL
NF-kB	NULL
site	NULL
from	NULL
the	NULL
HIV-2	NULL
enhancer	NULL
in	NULL
EMSAs	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Quantitative	NULL
analyses	NULL
of	NULL
the	NULL
protein-protein	NULL
binding	NULL
with	NULL
a	NULL
phosphorimager	NULL
revealed	NULL
that	NULL
mutant	NULL
proteins	NULL
containing	NULL
the	NULL
C-terminal	NULL
31	NULL
aa	NULL
from	NULL
the	NULL
Rel	NULL
HD	NULL
of	NULL
p65	NULL
bound	NULL
to	NULL
GST-EIf-1	NULL
at	NULL
least	NULL
30-fold	NULL
less	NULL
efficiently	NULL
than	NULL
proteins	NULL
containing	NULL
the	NULL
homologous	NULL
31-aa	NULL
region	NULL
from	NULL
the	NULL
p50	NULL
Rel	NULL
HD	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
experiments	NULL
mapped	NULL
the	NULL
Ets	NULL
binding	NULL
site	NULL
of	NULL
p50	NULL
to	NULL
aa	NULL
336	NULL
to	NULL
367	NULL
of	NULL
the	NULL
Rel	NULL
HD	NULL
.	NULL

EIf-1	NULL
associates	NULL
with	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
in	NULL
activated	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
demonstrate	NULL
a	NULL
physical	NULL
interaction	NULL
between	NULL
Ets	NULL
and	NULL
NF-kB/NFAT	NULL
in	NULL
vivo	NULL
,	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
were	NULL
activated	NULL
for	NULL
8	NULL
h	NULL
with	NULL
phorbal	NULL
myristate	NULL
acetate	NULL
plus	NULL
ionomy-cin	NULL
,	NULL
and	NULL
cell	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
different	NULL
NF-	NULL
«	NULL
kB/NFAT	NULL
proteins	NULL
.	NULL

These	NULL
immunoprecipitates	NULL
were	NULL
subsequently	NULL
denatured	NULL
and	NULL
subjected	NULL
to	NULL
immunoblot	NULL
analysis	NULL
with	NULL
an	NULL
«	NULL
-Elf-1	NULL
MAb	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Elf-1	NULL
was	NULL
coimmunoprecipitated	NULL
with	NULL
NFAT	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
and	NULL
p50	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

These	NULL
coimmunoprecipitations	NULL
represented	NULL
specific	NULL
Elf-1-NF-	NULL
«	NULL
kB/NFAT	NULL
interactions	NULL
,	NULL
because	NULL
Elf-1	NULL
failed	NULL
to	NULL
coimmunoprecipitate	NULL
in	NULL
parallel	NULL
experiments	NULL
that	NULL
used	NULL
the	NULL
Ets-NF-	NULL
«	NULL
B/NFAT	NULL
PHYSICAL	NULL
INTERACTION	NULL
-	NULL
3567	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
illustration	NULL
of	NULL
full-length	NULL
and	NULL
truncated	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
proteins	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
Rel	NULL
HDs	NULL
(	NULL
73	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

Amino	NULL
acid	NULL
numbers	NULL
are	NULL
shown	NULL
below	NULL
the	NULL
schematic	NULL
illustrations	NULL
of	NULL
the	NULL
proteins	NULL
.	NULL

Binding	NULL
(	NULL
+	NULL
)	NULL
or	NULL
lack	NULL
of	NULL
binding	NULL
(	NULL
-	NULL
)	NULL
to	NULL
GST-EIf-1	NULL
is	NULL
indicated	NULL
under	NULL
Elf-1	NULL
Association	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Mapping	NULL
of	NULL
the	NULL
Ets	NULL
interaction	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
proteins	NULL
.	NULL

The	NULL
*°S-labeled	NULL
in	NULL
vitro-translated	NULL
NF-kB/NFAT	NULL
proteins	NULL
shown	NULL
in	NULL
panel	NULL
A	NULL
were	NULL
mixed	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
GST-Elf-1	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
mixtures	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

S-labeled	NULL
in	NULL
vitro-translated	NULL
(	NULL
IVT	NULL
)	NULL
NF-xB/NFAT	NULL
proteins	NULL
were	NULL
run	NULL
directly	NULL
in	NULL
parallel	NULL
on	NULL
the	NULL
same	NULL
gel	NULL
.	NULL

Size	NULL
markers	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
are	NULL
shown	NULL
to	NULL
the	NULL
left	NULL
of	NULL
the	NULL
autoradiogram	NULL
.	NULL

m	NULL
in	NULL
§	NULL
§	NULL
$	NULL
8	NULL
4	NULL
F	NULL
gf	NULL
¢	NULL
A	NULL
6	NULL
€	NULL
Co	NULL
~	NULL
~	NULL
-NFATe	NULL
-	NULL
NFATp	NULL
-	NULL
NFATe	NULL
*	NULL
asthe	NULL
|	NULL
=	NULL
[	NULL
2241-295	NULL
,	NULL
PS511-304	NULL
NFATP521-890	NULL
-	NULL
NFATEq18-716	NULL
P5O3g.367	NULL
16	NULL
17	NULL
18	NULL
same	NULL
cell	NULL
extracts	NULL
and	NULL
control	NULL
antibodies	NULL
directed	NULL
against	NULL
the	NULL
CREM	NULL
,	NULL
c-Myc	NULL
,	NULL
and	NULL
c-Myb	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Reciprocal	NULL
experiments	NULL
demonstrated	NULL
that	NULL
NFAT	NULL
could	NULL
be	NULL
coimmunoprecipitated	NULL
from	NULL
activated	NULL
human	NULL
T-cell	NULL
extracts	NULL
by	NULL
using	NULL
a	NULL
MAb	NULL
directed	NULL
against	NULL
Elf-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
experiments	NULL
demonstrated	NULL
a	NULL
physical	NULL
interaction	NULL
between	NULL
the	NULL
Ets-related	NULL
protein	NULL
Elf-1	NULL
and	NULL
NF-	NULL
«	NULL
kB/NFAT	NULL
proteins	NULL
in	NULL
activated	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
Ets-NF-KB/NFAT	NULL
interaction	NULL
requires	NULL
DNA	NULL
binding	NULL
sites	NULL
for	NULL
both	NULL
proteins	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
Elf-1-NF-kB/NFAT	NULL
interactions	NULL
required	NULL
DNA	NULL
binding	NULL
sites	NULL
for	NULL
these	NULL
proteins	NULL
,	NULL
the	NULL
in	NULL
vitro	NULL
binding	NULL
experiments	NULL
were	NULL
repeated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
EtBr	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
disrupt	NULL
DNA-protein	NULL
interactions	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
Elf-1-p50	NULL
and	NULL
the	NULL
Elf-1-NFATc	NULL
interactions	NULL
were	NULL
significantly	NULL
reduced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
EtBr	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
;	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

The	NULL
abrogation	NULL
of	NULL
the	NULL
and	NULL
Elf-1-NFATc	NULL
complexes	NULL
by	NULL
EtBr	NULL
was	NULL
specific	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B/NFAT-Ets	NULL
interactions	NULL
because	NULL
similar	NULL
concentrations	NULL
of	NULL
EtBr	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
previously	NULL
described	NULL
physical	NULL
interaction	NULL
between	NULL
the	NULL
Elf-1	NULL
and	NULL
c-Jun	NULL
proteins	NULL
,	NULL
which	NULL
does	NULL
not	NULL
require	NULL
DNA	NULL
(	NULL
3	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3568	NULL
BASSUK	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
Rel	NULL
HD	NULL
Elf	NULL
-1	NULL
Association	NULL
ro	NULL
--	NULL
--	NULL
-1	NULL
P5036.-367	NULL
—3|s_	NULL
:	NULL
|367—	NULL
+	NULL
-e-	NULL
=~	NULL
11	NULL
304	NULL
-__	NULL
S-	NULL
-G	NULL
|-	NULL
+	NULL
p50/p65	NULL
chimera	NULL
1	NULL
p65/p50	NULL
chimera	NULL
3	NULL
p50/p65	NULL
chimera	NULL
5	NULL
p65/p50	NULL
chimera	NULL
6	NULL
B	NULL
GST-Elf-1	NULL
+	NULL
]	NULL
+/+	NULL
]	NULL
+/+	NULL
|+	NULL
-~	NULL
in	NULL
©	NULL
6	NULL
©	NULL
5	NULL
®	NULL
P5O3G.367	NULL
+	NULL
aE	NULL
;	NULL
aE	NULL
;	NULL
E	NULL
g	NULL
P6511-304	NULL
+	NULL
e	NULL
-	NULL
is	NULL
$	NULL
6	NULL
6	NULL
o	NULL
o	NULL
p50/p65	NULL
chimera	NULL
1	NULL
+	NULL
8	NULL
Su	NULL
o	NULL
u	NULL
9	NULL
&	NULL
1G	NULL
ip	NULL
©	NULL
p65/p50	NULL
chimera	NULL
3	NULL
+	NULL
$	NULL
coe	NULL
a	NULL
c	NULL
0	NULL
n	NULL
o	NULL
0	NULL
o	NULL
ip	NULL
p50/p65	NULL
chimera	NULL
5	NULL
+	NULL
3-44-41	NULL
p65/p50	NULL
chimera	NULL
6	NULL
+	NULL
E	NULL
E	NULL
E	NULL
S	NULL
E	NULL
S	NULL
961	NULL
69	NULL
46	NULL
«	NULL
w	NULL
ap	NULL
ow	NULL
***	NULL
``	NULL
am	NULL
_	NULL
SDS-PAGE	NULL
30	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
910	NULL
1112	NULL
v	NULL
..	NULL
®	NULL
..0	NULL
EMSA	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
illustration	NULL
of	NULL
the	NULL
chimeric	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
p65	NULL
proteins	NULL
.	NULL

The	NULL
Rel	NULL
HDs	NULL
are	NULL
shown	NULL
(	NULL
73	NULL
)	NULL
.	NULL

Regions	NULL
containing	NULL
amino	NULL
acids	NULL
from	NULL
p50	NULL
are	NULL
indicated	NULL
in	NULL
white	NULL
,	NULL
while	NULL
regions	NULL
containing	NULL
amino	NULL
acids	NULL
from	NULL
p65	NULL
are	NULL
shaded	NULL
.	NULL

Binding	NULL
(	NULL
+	NULL
)	NULL
or	NULL
lack	NULL
of	NULL
binding	NULL
(	NULL
-	NULL
)	NULL
of	NULL
these	NULL
chimeric	NULL
proteins	NULL
to	NULL
GST-Elf-1	NULL
is	NULL
indicated	NULL
under	NULL
Elf-1	NULL
Association	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Fine	NULL
mapping	NULL
of	NULL
the	NULL
Ets	NULL
interaction	NULL
domain	NULL
of	NULL
p50	NULL
.	NULL

The	NULL
*°S-labeled	NULL
in	NULL
vitro-translated	NULL
proteins	NULL
shown	NULL
in	NULL
panel	NULL
A	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
GST-EIf-1	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
mixtures	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Size	NULL
markers	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
are	NULL
shown	NULL
to	NULL
the	NULL
left	NULL
of	NULL
the	NULL
autoradiogram	NULL
.	NULL

The	NULL
in	NULL
vitro-translated	NULL
(	NULL
IVT	NULL
)	NULL
chimeric	NULL
proteins	NULL
were	NULL
also	NULL
used	NULL
in	NULL
EMSAs	NULL
with	NULL
a	NULL
°P-labeled	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
from	NULL
the	NULL
HIV-2	NULL
enhancer	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
all	NULL
of	NULL
the	NULL
chimeric	NULL
proteins	NULL
retain	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

3	NULL
;	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

To	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
observed	NULL
disruption	NULL
of	NULL
the	NULL
EIf-1-NF-	NULL
«	NULL
B/NFAT	NULL
interaction	NULL
by	NULL
EtBr	NULL
was	NULL
due	NULL
to	NULL
a	NULL
nonspecific	NULL
effect	NULL
of	NULL
EtBr	NULL
on	NULL
the	NULL
NF-kB/	NULL
NFAT	NULL
or	NULL
Ets	NULL
protein	NULL
,	NULL
a	NULL
second	NULL
set	NULL
of	NULL
binding	NULL
experiments	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
DNA	NULL
intercalating	NULL
agent	NULL
PI	NULL
,	NULL
which	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
specifically	NULL
disrupt	NULL
DNA-protein	NULL
interactions	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
our	NULL
results	NULL
with	NULL
EtBr	NULL
,	NULL
the	NULL
Elf-1-p50	NULL
interaction	NULL
was	NULL
eliminated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PI	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
PI	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
the	NULL
Elf-1-c-Jun	NULL
interaction	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
experiments	NULL
were	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
both	NULL
Ets	NULL
and	NULL
NF-kB/NFAT	NULL
proteins	NULL
,	NULL
as	NULL
well	NULL
as	NULL
an	NULL
appropriate	NULL
DNA	NULL
molecule	NULL
,	NULL
are	NULL
required	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
ternary	NULL
complex	NULL
containing	NULL
all	NULL
three	NULL
molecules	NULL
.	NULL

As	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
,	NULL
the	NULL
reticulocyte	NULL
and	NULL
bacterial	NULL
lysates	NULL
used	NULL
in	NULL
the	NULL
binding	NULL
experiments	NULL
contain	NULL
small	NULL
amounts	NULL
of	NULL
DNA	NULL
molecules	NULL
,	NULL
which	NULL
may	NULL
allow	NULL
complex	NULL
formation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
added	NULL
DNA	NULL
(	NULL
51	NULL
)	NULL
.	NULL

As	NULL
a	NULL
further	NULL
test	NULL
of	NULL
the	NULL
importance	NULL
of	NULL
a	NULL
DNA	NULL
molecule	NULL
J.	NULL
ViRoL	NULL
.	NULL

containing	NULL
intact	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
Elf-1-p50	NULL
ternary	NULL
complex	NULL
,	NULL
we	NULL
incubated	NULL
GST-Elf-1	NULL
with	NULL
°°S-labeled	NULL
in	NULL
vitro-translated	NULL
p50	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
a	NULL
wild-type	NULL
HIV-2	NULL
enhancer	NULL
fragment	NULL
containing	NULL
intact	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Ets	NULL
binding	NULL
sites	NULL
or	NULL
a	NULL
mutant	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
but	NULL
an	NULL
intact	NULL
Ets	NULL
binding	NULL
site	NULL
(	NULL
mB	NULL
)	NULL
.	NULL

GST-Elf-1-p50	NULL
binding	NULL
was	NULL
significantly	NULL
increased	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
wild-type	NULL
HIV-2	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
2	NULL
through	NULL
5	NULL
)	NULL
but	NULL
not	NULL
by	NULL
the	NULL
HIV-2	NULL
m	NULL
«	NULL
B	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
6	NULL
through	NULL
9	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
using	NULL
three	NULL
different	NULL
experimental	NULL
protocols	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
both	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
xB/NFAT	NULL
proteins	NULL
,	NULL
as	NULL
well	NULL
as	NULL
an	NULL
appropriate	NULL
DNA	NULL
molecule	NULL
,	NULL
are	NULL
required	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
ternary	NULL
complex	NULL
containing	NULL
all	NULL
three	NULL
molecules	NULL
.	NULL

These	NULL
findings	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
observed	NULL
physical	NULL
association	NULL
between	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
proteins	NULL
simply	NULL
reflected	NULL
the	NULL
simultaneous	NULL
binding	NULL
of	NULL
both	NULL
proteins	NULL
to	NULL
a	NULL
single	NULL
DNA	NULL
molecule	NULL
.	NULL

However	NULL
,	NULL
this	NULL
was	NULL
shown	NULL
not	NULL
to	NULL
be	NULL
the	NULL
case	NULL
in	NULL
the	NULL
chimeric	NULL
protein	NULL
experiments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
.	NULL

Thus	NULL
,	NULL
for	NULL
example	NULL
,	NULL
chimeric	NULL
NF-	NULL
«	NULL
B	NULL
molecules	NULL
such	NULL
as	NULL
p50/p65	NULL
chimeras	NULL
1	NULL
and	NULL
5	NULL
were	NULL
shown	NULL
by	NULL
EMSA	NULL
to	NULL
bind	NULL
to	NULL
DNA	NULL
with	NULL
high	NULL
affinity	NULL
.	NULL

However	NULL
,	NULL
these	NULL
molecules	NULL
failed	NULL
to	NULL
associate	NULL
with	NULL
Ets	NULL
proteins	NULL
.	NULL

Therefore	NULL
,	NULL
DNA	NULL
binding	NULL
is	NULL
necessary	NULL
but	NULL
not	NULL
sufficient	NULL
for	NULL
the	NULL
Ets-NFAT/	NULL
NF-	NULL
«	NULL
B	NULL
interaction	NULL
.	NULL

Several	NULL
models	NULL
that	NULL
might	NULL
account	NULL
for	NULL
this	NULL
type	NULL
of	NULL
interaction	NULL
are	NULL
described	NULL
in	NULL
detail	NULL
below	NULL
(	NULL
see	NULL
Discus-sion	NULL
)	NULL
.	NULL

Physical	NULL
interactions	NULL
between	NULL
Ets	NULL
and	NULL
NF-KB	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
synergistic	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
and	NULL
HIV-2	NULL
enhancers	NULL
.	NULL

It	NULL
was	NULL
shown	NULL
previously	NULL
that	NULL
both	NULL
Ets	NULL
and	NULL
NF-kB	NULL
proteins	NULL
can	NULL
independently	NULL
activate	NULL
transcription	NULL
from	NULL
reporter	NULL
constructs	NULL
containing	NULL
the	NULL
HIV-1	NULL
or	NULL
HIV-2	NULL
enhancers	NULL
(	NULL
38	NULL
,	NULL
40	NULL
,	NULL
62	NULL
,	NULL
71	NULL
,	NULL
86	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
Ets	NULL
and	NULL
NF-kB	NULL
proteins	NULL
can	NULL
cooperatively	NULL
activate	NULL
transcription	NULL
in	NULL
vivo	NULL
and	NULL
,	NULL
if	NULL
they	NULL
can	NULL
,	NULL
whether	NULL
physical	NULL
interaction	NULL
between	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
required	NULL
for	NULL
this	NULL
activity	NULL
,	NULL
COS	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
luciferase	NULL
reporter	NULL
construct	NULL
containing	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
intact	NULL
HIV-1	NULL
enhancer	NULL
in	NULL
conjunction	NULL
with	NULL
various	NULL
combinations	NULL
of	NULL
eukaryotic	NULL
expression	NULL
vectors	NULL
encoding	NULL
different	NULL
Ets	NULL
and	NULL
NF-kB	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

COS	NULL
cells	NULL
rather	NULL
than	NULL
T	NULL
cells	NULL
were	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
because	NULL
T	NULL
cells	NULL
express	NULL
high	NULL
endogenous	NULL
levels	NULL
of	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Ets	NULL
proteins	NULL
.	NULL

Overexpression	NULL
of	NULL
either	NULL
Ets-1	NULL
or	NULL
NF-kB	NULL
(	NULL
p50	NULL
+	NULL
p65	NULL
)	NULL
alone	NULL
resulted	NULL
in	NULL
approximately	NULL
fivefold	NULL
transactivation	NULL
of	NULL
the	NULL
HIV-1	NULL
reporter	NULL
construct	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cotransfection	NULL
of	NULL
Ets-1	NULL
and	NULL
NF-kB	NULL
expression	NULL
constructs	NULL
resulted	NULL
in	NULL
18-fold	NULL
transactivation	NULL
.	NULL

Thus	NULL
,	NULL
Ets-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
synergistically	NULL
induce	NULL
HIV-1	NULL
transcription	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
the	NULL
physical	NULL
interaction	NULL
between	NULL
Ets	NULL
and	NULL
NF-kB	NULL
in	NULL
mediating	NULL
this	NULL
cooperative	NULL
effect	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
effect	NULL
of	NULL
overexpressing	NULL
the	NULL
p50/p65	NULL
chimera	NULL
5	NULL
full	NULL
0	NULL
§	NULL
AEEEARIRE	NULL
8	NULL
q	NULL
f	NULL
&	NULL
f	NULL
%	NULL
i-	NULL
8	NULL
8	NULL
&	NULL
0	NULL
8	NULL
Elf-1-+	NULL
»	NULL
®	NULL
wan	NULL
«	NULL
»	NULL
-	NULL
97kD	NULL
1	NULL
Z	NULL
)	NULL
%	NULL
4	NULL
6	NULL
\	NULL
6	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Elf-1	NULL
associates	NULL
with	NULL
p50	NULL
and	NULL
NFAT	NULL
proteins	NULL
in	NULL
activated	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
extracts	NULL
from	NULL
activated	NULL
human	NULL
peripheral	NULL
T	NULL
cells	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
CREM	NULL
,	NULL
Myc	NULL
,	NULL
NFATp/c	NULL
,	NULL
Myb	NULL
,	NULL
or	NULL
p50	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
denatured	NULL
,	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
protein	NULL
immunoblot	NULL
analysis	NULL
with	NULL
an	NULL
a-Elf-1	NULL
MAb	NULL
.	NULL

Whole	NULL
T-cell	NULL
extract	NULL
(	NULL
T	NULL
cell	NULL
extract	NULL
)	NULL
was	NULL
electrophoresed	NULL
in	NULL
parallel	NULL
on	NULL
the	NULL
same	NULL
gel	NULL
.	NULL

The	NULL
97-kDa	NULL
size	NULL
marker	NULL
is	NULL
shown	NULL
to	NULL
the	NULL
right	NULL
of	NULL
the	NULL
autoradiogram	NULL
.	NULL

Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
A	NULL
GST-EIf-1	NULL
+	NULL
|+	NULL
]	NULL
+|+	NULL
]	NULL
+	NULL
]	NULL
+	NULL
c-Jun	NULL
+	NULL
|+	NULL
|	NULL
+	NULL
o	NULL
5	NULL
f	NULL
NFAT	NULL
+	NULL
]	NULL
+	NULL
]	NULL
+	NULL
2	NULL
o	NULL
EtBr	NULL
(	NULL
ug/ml	NULL
)	NULL
|	NULL
|9	NULL
8.	NULL
o	NULL
8	NULL
.	NULL

55	NULL
97	NULL
-	NULL
l	NULL
U	NULL
-	NULL
NFATe	NULL
ae	NULL
®	NULL
.	NULL

:	NULL
|c-Jun	NULL
46	NULL
-	NULL
is	NULL
ti	NULL
212	NULL
29	NULL
7	NULL
8	NULL
B	NULL
GST-Elf-1	NULL
c-Jun	NULL
o	NULL
D	NULL
o.	NULL
EtBr	NULL
5	NULL
fuss	NULL
t—pSO	NULL
C	NULL
BC	NULL
|..	NULL
ho	NULL
_	NULL
:	NULL
|c	NULL
Jun	NULL
38	NULL
C	NULL
GST-Elf-1	NULL
+	NULL
]	NULL
+	NULL
]	NULL
+	NULL
|+|+|+	NULL
p50	NULL
+	NULL
|	NULL
+	NULL
]	NULL
+	NULL
o	NULL
g	NULL
5	NULL
c-Jun	NULL
2	NULL
B	NULL
PI	NULL
(	NULL
ug/m1	NULL
)	NULL
Rle|	NULL
|Ble	NULL
]	NULL
|	NULL
&	NULL
5	NULL
the	NULL
-	NULL
p50	NULL
a=	NULL
#	NULL
jlc—Jun	NULL
46~-	NULL
7	NULL
8	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EtBr	NULL
specifically	NULL
abrogates	NULL
the	NULL
Elf-1-NFATc	NULL
association	NULL
.	NULL

Equivalent	NULL
molar	NULL
amounts	NULL
of	NULL
*°S-labeled	NULL
in	NULL
vitro-translated	NULL
(	NULL
IVT	NULL
)	NULL
c-Jun	NULL
and	NULL
NFATe	NULL
were	NULL
mixed	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
bacterially	NULL
expressed	NULL
GST-Elf-1	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
either	NULL
10	NULL
or	NULL
100	NULL
ug	NULL
of	NULL
EtBr	NULL
per	NULL
ml	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EtBr	NULL
specifically	NULL
abrogates	NULL
the	NULL
Elf-1-p50	NULL
association	NULL
.	NULL

Equivalent	NULL
molar	NULL
amounts	NULL
of	NULL
*°S-labeled	NULL
in	NULL
vitro-translated	NULL
c-Jun	NULL
and	NULL
p50	NULL
were	NULL
mixed	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
bacterially	NULL
expressed	NULL
GST-Elf-1	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
10	NULL
ug	NULL
of	NULL
EtBr	NULL
per	NULL
ml	NULL
.	NULL

(	NULL
C	NULL
)	NULL
PI	NULL
specifically	NULL
abrogates	NULL
the	NULL
Elf-1-p50	NULL
association	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
S-labeled	NULL
in	NULL
vitro-translated	NULL
p50	NULL
and	NULL
c-Jun	NULL
were	NULL
mixed	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
bacterially	NULL
expressed	NULL
GST-Elf-1	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
either	NULL
7.5	NULL
or	NULL
15	NULL
ug	NULL
of	NULL
PI	NULL
per	NULL
ml	NULL
.	NULL

The	NULL
protein	NULL
complexes	NULL
were	NULL
denatured	NULL
and	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
prior	NULL
to	NULL
autoradiogra-phy	NULL
.	NULL

S-labeled	NULL
in	NULL
vitro-translated	NULL
proteins	NULL
were	NULL
run	NULL
directly	NULL
in	NULL
parallel	NULL
on	NULL
the	NULL
same	NULL
gels	NULL
.	NULL

Size	NULL
markers	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
are	NULL
shown	NULL
to	NULL
the	NULL
left	NULL
of	NULL
each	NULL
autoradiogram	NULL
.	NULL

length	NULL
protein	NULL
in	NULL
conjunction	NULL
with	NULL
Ets-1	NULL
and	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
on	NULL
HIV-1	NULL
enhancer-mediated	NULL
transcription	NULL
.	NULL

The	NULL
p50/p65	NULL
chimera	NULL
5	NULL
protein	NULL
retains	NULL
the	NULL
abilities	NULL
to	NULL
bind	NULL
to	NULL
DNA	NULL
and	NULL
to	NULL
associate	NULL
with	NULL
p65	NULL
but	NULL
fails	NULL
to	NULL
associate	NULL
with	NULL
Ets	NULL
proteins	NULL
because	NULL
the	NULL
31-aa	NULL
C-terminal	NULL
Ets	NULL
binding	NULL
domain	NULL
of	NULL
p50	NULL
has	NULL
been	NULL
replaced	NULL
with	NULL
the	NULL
homologous	NULL
region	NULL
of	NULL
p65	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
the	NULL
p50/p65	NULL
chimera	NULL
5	NULL
protein	NULL
significantly	NULL
decreased	NULL
Ets-1/NF-	NULL
«	NULL
kB	NULL
(	NULL
p50	NULL
+	NULL
p65	NULL
)	NULL
-mediated	NULL
transcription	NULL
Ets-NF-	NULL
«	NULL
B/NFAT	NULL
PHYSICAL	NULL
INTERACTION	NULL
-	NULL
3569	NULL
from	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
.	NULL

The	NULL
resulting	NULL
level	NULL
of	NULL
transcription	NULL
was	NULL
approximately	NULL
equivalent	NULL
to	NULL
the	NULL
level	NULL
observed	NULL
following	NULL
overexpression	NULL
of	NULL
Ets-1	NULL
alone	NULL
.	NULL

It	NULL
was	NULL
suggested	NULL
previously	NULL
that	NULL
p50	NULL
homodimers	NULL
can	NULL
repress	NULL
transcription	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
such	NULL
a	NULL
direct	NULL
inhibitory	NULL
effect	NULL
by	NULL
the	NULL
p50/p65	NULL
chimeric	NULL
protein	NULL
,	NULL
we	NULL
cotransfected	NULL
equal	NULL
amounts	NULL
of	NULL
wild-type	NULL
p50	NULL
in	NULL
combination	NULL
with	NULL
Ets-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
inhibition	NULL
observed	NULL
following	NULL
overexpression	NULL
of	NULL
the	NULL
p50/p65	NULL
chimera	NULL
5	NULL
protein	NULL
,	NULL
overexpression	NULL
of	NULL
wild-type	NULL
p50	NULL
resulted	NULL
in	NULL
a	NULL
slight	NULL
increase	NULL
in	NULL
transactivation	NULL
(	NULL
20-fold	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
inhibition	NULL
mediated	NULL
by	NULL
the	NULL
p50/p65	NULL
chimera	NULL
5	NULL
protein	NULL
was	NULL
specifically	NULL
due	NULL
to	NULL
the	NULL
inability	NULL
of	NULL
this	NULL
protein	NULL
to	NULL
interact	NULL
with	NULL
Ets-1	NULL
.	NULL

In	NULL
similar	NULL
experiments	NULL
,	NULL
overexpression	NULL
of	NULL
both	NULL
Ets-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
p50	NULL
+	NULL
p65	NULL
)	NULL
in	NULL
COS	NULL
cells	NULL
resulted	NULL
in	NULL
an	NULL
approximately	NULL
threefold	NULL
induction	NULL
of	NULL
the	NULL
HIV-2	NULL
reporter	NULL
construct	NULL
.	NULL

This	NULL
induction	NULL
required	NULL
binding	NULL
sites	NULL
for	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Ets-1	NULL
proteins	NULL
,	NULL
since	NULL
mutations	NULL
in	NULL
either	NULL
binding	NULL
site	NULL
abolished	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
reporter	NULL
construct	NULL
following	NULL
coexpression	NULL
of	NULL
both	NULL
transcription	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

This	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
in	NULL
vitro	NULL
binding	NULL
experiments	NULL
that	NULL
demonstrated	NULL
that	NULL
binding	NULL
sites	NULL
for	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Ets	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
their	NULL
physical	NULL
interaction	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
a	NULL
physical	NULL
interaction	NULL
between	NULL
Ets	NULL
and	NULL
NF-kB/NFAT	NULL
transcription	NULL
factors	NULL
that	NULL
is	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
and	NULL
HIV-2	NULL
enhancers	NULL
.	NULL

This	NULL
interaction	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
DNA	NULL
binding	NULL
domains	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
:	NULL
the	NULL
Ets	NULL
domain	NULL
of	NULL
the	NULL
Ets	NULL
proteins	NULL
and	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
the	NULL
Rel	NULL
HD	NULL
of	NULL
some	NULL
,	NULL
but	NULL
not	NULL
all	NULL
,	NULL
NF-	NULL
«	NULL
B/	NULL
NFAT	NULL
proteins	NULL
.	NULL

The	NULL
binding	NULL
sites	NULL
on	NULL
both	NULL
proteins	NULL
have	NULL
been	NULL
highly	NULL
conserved	NULL
during	NULL
vertebrate	NULL
evolution	NULL
.	NULL

Thus	NULL
,	NULL
each	NULL
of	NULL
the	NULL
distantly	NULL
related	NULL
Ets	NULL
proteins	NULL
Ets-1	NULL
,	NULL
Elf-1	NULL
,	NULL
and	NULL
PU.1	NULL
retains	NULL
the	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
multiple	NULL
,	NULL
distantly	NULL
related	NULL
proteins	NULL
,	NULL
including	NULL
p50	NULL
,	NULL
c-Rel	NULL
,	NULL
NFATc	NULL
,	NULL
and	NULL
NFATp	NULL
.	NULL

This	NULL
degree	NULL
of	NULL
evolutionary	NULL
conservation	NULL
suggests	NULL
an	NULL
important	NULL
function	NULL
for	NULL
this	NULL
protein-protein	NULL
interaction	NULL
in	NULL
regulating	NULL
mammalian	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
association	NULL
between	NULL
NF-	NULL
«	NULL
kB/NFAT	NULL
and	NULL
Ets	NULL
proteins	NULL
also	NULL
requires	NULL
a	NULL
DNA	NULL
molecule	NULL
in	NULL
that	NULL
it	NULL
is	NULL
inhibited	NULL
by	NULL
EtBr	NULL
and	NULL
PI	NULL
and	NULL
facilitated	NULL
by	NULL
exogenous	NULL
DNA	NULL
containing	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Ets	NULL
binding	NULL
sites	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
association	NULL
involves	NULL
(	NULL
at	NULL
minimum	NULL
)	NULL
a	NULL
tripartite	NULL
complex	NULL
composed	NULL
of	NULL
an	NULL
appropriate	NULL
DNA	NULL
molecule	NULL
with	NULL
bound	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
proteins	NULL
.	NULL

The	NULL
role	NULL
of	NULL
DNA	NULL
in	NULL
the	NULL
Ets-NF-KB/NFAT	NULL
interaction	NULL
.	NULL

Our	NULL
studies	NULL
demonstrate	NULL
that	NULL
DNA	NULL
binding	NULL
is	NULL
necessary	NULL
but	NULL
not	NULL
sufficient	NULL
for	NULL
the	NULL
observed	NULL
physical	NULL
interactions	NULL
between	NULL
Ets	NULL
+	NULL
p50	NULL
HIV-2	NULL
WT	NULL
(	NULL
e	NULL
GST-Ef-1	NULL
+	NULL
p50	NULL
HIV-2	NULL
m	NULL
«	NULL
B	NULL
oooh	NULL
«	NULL
-	NULL
-	NULL
p50	NULL
46	NULL
Relative	NULL
Elf-1-p50	NULL
Binding	NULL
:	NULL
2	NULL
2	NULL
2	NULL
{	NULL
$	NULL
C	NULL
g	NULL
P	NULL
PF	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

GST-Elf-1-p50	NULL
binding	NULL
is	NULL
increased	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
DNA	NULL
containing	NULL
binding	NULL
sites	NULL
for	NULL
both	NULL
proteins	NULL
.	NULL

S-labeled	NULL
in	NULL
vitro-translated	NULL
p50	NULL
was	NULL
incubated	NULL
with	NULL
60	NULL
ng	NULL
of	NULL
bacterially	NULL
expressed	NULL
GST-EIf-1	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
no	NULL
DNA	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
of	NULL
35	NULL
ng	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
70	NULL
ng	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
140	NULL
ng	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
350	NULL
ng	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
of	NULL
HIV-2	NULL
wild-type	NULL
DNA	NULL
or	NULL
of	NULL
35	NULL
ng	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
70	NULL
ng	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
140	NULL
ng	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
or	NULL
350	NULL
ng	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
of	NULL
HIV-2	NULL
m	NULL
«	NULL
B	NULL
DNA	NULL
.	NULL

The	NULL
resulting	NULL
complexes	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Size	NULL
markers	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
.	NULL

Relative	NULL
Elf-1-p50	NULL
binding	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
phosphorimager	NULL
analysis	NULL
,	NULL
is	NULL
indicated	NULL
for	NULL
each	NULL
reaction	NULL
.	NULL

3570	NULL
BASSUK	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
€	NULL
&	NULL
3	NULL
#	NULL
#	NULL
o	NULL
2	NULL
&	NULL
E	NULL
3	NULL
4g	NULL
3	NULL
3	NULL
®	NULL
&	NULL
3	NULL
©	NULL
[	NULL
ra	NULL
Ets-1	NULL
p50	NULL
+	NULL
p65	NULL
p50	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
p50/p65	NULL
chimera	NULL
5	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
HIV-1	NULL
Luc	NULL
J.	NULL
ViRoL	NULL
.	NULL

Relative	NULL
Luciferase	NULL
Activity	NULL
HIV-2	NULL
WT	NULL
Luc	NULL
HIV-2	NULL
maB	NULL
Luc	NULL
HIV-2	NULL
mEts	NULL
Luc	NULL
Ets-1	NULL
+	NULL
+	NULL
*	NULL
p50	NULL
+	NULL
pes	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Cooperative	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
and	NULL
HIV-2	NULL
enhancers	NULL
by	NULL
Ets-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
.	NULL

(	NULL
A	NULL
)	NULL
COS	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
1	NULL
g	NULL
of	NULL
HIV-1	NULL
Luc	NULL
reporter	NULL
plasmid	NULL
and	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
Ets-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
plasmids	NULL
.	NULL

Each	NULL
transfection	NULL
mixture	NULL
contained	NULL
a	NULL
total	NULL
of	NULL
21	NULL
pg	NULL
of	NULL
DNA	NULL
,	NULL
including	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
RSV-B-galactosidase	NULL
reference	NULL
plasmid	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
prepared	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
normalized	NULL
for	NULL
protein	NULL
content	NULL
,	NULL
and	NULL
analyzed	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
.	NULL

The	NULL
data	NULL
are	NULL
shown	NULL
as	NULL
mean	NULL
luciferase	NULL
activity	NULL
(	NULL
+	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
)	NULL
relative	NULL
to	NULL
that	NULL
observed	NULL
following	NULL
transfection	NULL
of	NULL
the	NULL
same	NULL
cells	NULL
with	NULL
the	NULL
HIV-1	NULL
Luc	NULL
reporter	NULL
plasmid	NULL
and	NULL
p50	NULL
and	NULL
p65	NULL
expression	NULL
plasmids	NULL
after	NULL
correction	NULL
for	NULL
differences	NULL
in	NULL
transfection	NULL
efficiencies	NULL
.	NULL

In	NULL
vitro-translated	NULL
p50	NULL
and	NULL
p50/p65	NULL
chimera	NULL
proteins	NULL
were	NULL
also	NULL
assayed	NULL
for	NULL
DNA	NULL
binding	NULL
activity	NULL
by	NULL
EMSA	NULL
,	NULL
using	NULL
a	NULL
radiolabeled	NULL
oligonucleotide	NULL
probe	NULL
from	NULL
the	NULL
HIV-2	NULL
enhancer	NULL
.	NULL

(	NULL
B	NULL
)	NULL
COS	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
the	NULL
HIV-2wtLuc	NULL
,	NULL
HIV-Z2m	NULL
«	NULL
BLuc	NULL
,	NULL
or	NULL
HIV-2mEtsLuc	NULL
reporter	NULL
plasmids	NULL
along	NULL
with	NULL
3	NULL
pg	NULL
of	NULL
Ets-1	NULL
and	NULL
1	NULL
pg	NULL
each	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
NF-xB	NULL
p65	NULL
expression	NULL
plasmids	NULL
.	NULL

Each	NULL
transfection	NULL
contained	NULL
a	NULL
total	NULL
of	NULL
12	NULL
ug	NULL
of	NULL
DNA	NULL
,	NULL
including	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
RSV-B-galactosidase	NULL
reference	NULL
plasmid	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
prepared	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
normalized	NULL
for	NULL
protein	NULL
content	NULL
,	NULL
and	NULL
analyzed	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
.	NULL

The	NULL
data	NULL
are	NULL
shown	NULL
as	NULL
luciferase	NULL
activity	NULL
relative	NULL
to	NULL
that	NULL
observed	NULL
following	NULL
transfection	NULL
of	NULL
the	NULL
same	NULL
cells	NULL
with	NULL
the	NULL
appropriate	NULL
HIV-2	NULL
Luc	NULL
reporter	NULL
plasmid	NULL
alone	NULL
after	NULL
correction	NULL
for	NULL
differences	NULL
in	NULL
transfection	NULL
efficiencies	NULL
.	NULL

and	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
proteins	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
our	NULL
results	NULL
differ	NULL
significantly	NULL
from	NULL
those	NULL
of	NULL
a	NULL
previous	NULL
study	NULL
that	NULL
reported	NULL
that	NULL
EtBr	NULL
does	NULL
not	NULL
disrupt	NULL
a	NULL
physical	NULL
interaction	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
Elf-1	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
this	NULL
difference	NULL
is	NULL
unclear	NULL
.	NULL

However	NULL
,	NULL
it	NULL
should	NULL
be	NULL
emphasized	NULL
that	NULL
we	NULL
have	NULL
confirmed	NULL
our	NULL
findings	NULL
using	NULL
multiple	NULL
concentrations	NULL
of	NULL
two	NULL
different	NULL
DNA	NULL
intercalating	NULL
agents	NULL
(	NULL
EtBr	NULL
and	NULL
PI	NULL
)	NULL
and	NULL
have	NULL
also	NULL
shown	NULL
a	NULL
dose-dependent	NULL
increase	NULL
in	NULL
Ets-NF-	NULL
«	NULL
B	NULL
association	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
DNA	NULL
containing	NULL
adjacent	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
observed	NULL
Ets-NF-	NULL
«	NULL
B	NULL
interaction	NULL
does	NULL
not	NULL
simply	NULL
reflect	NULL
simultaneous	NULL
binding	NULL
of	NULL
both	NULL
proteins	NULL
to	NULL
a	NULL
single	NULL
DNA	NULL
molecule	NULL
,	NULL
because	NULL
chimeric	NULL
p50/p65	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
DNA	NULL
with	NULL
high	NULL
affinity	NULL
fail	NULL
to	NULL
interact	NULL
with	NULL
Ets	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Several	NULL
possible	NULL
models	NULL
might	NULL
account	NULL
for	NULL
the	NULL
role	NULL
of	NULL
DNA	NULL
in	NULL
the	NULL
Ets-NF-kB	NULL
interaction	NULL
.	NULL

First	NULL
,	NULL
the	NULL
DNA	NULL
(	NULL
with	NULL
appropriate	NULL
cognate	NULL
binding	NULL
sites	NULL
)	NULL
might	NULL
serve	NULL
to	NULL
increase	NULL
the	NULL
local	NULL
concentrations	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
,	NULL
thereby	NULL
facilitating	NULL
their	NULL
interactions	NULL
.	NULL

In	NULL
such	NULL
a	NULL
model	NULL
,	NULL
both	NULL
protein-DNA	NULL
and	NULL
protein-protein	NULL
interactions	NULL
might	NULL
stabilize	NULL
the	NULL
tripartite	NULL
DNA-Ets-NF-	NULL
«	NULL
B/NFAT	NULL
complex	NULL
.	NULL

In	NULL
a	NULL
second	NULL
model	NULL
,	NULL
binding	NULL
of	NULL
one	NULL
or	NULL
both	NULL
proteins	NULL
to	NULL
the	NULL
DNA	NULL
might	NULL
produce	NULL
conforma-tional	NULL
changes	NULL
that	NULL
expose	NULL
the	NULL
binding	NULL
site	NULL
(	NULL
s	NULL
)	NULL
for	NULL
the	NULL
other	NULL
protein	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
it	NULL
is	NULL
of	NULL
interest	NULL
that	NULL
the	NULL
sites	NULL
of	NULL
protein-protein	NULL
interactions	NULL
on	NULL
both	NULL
the	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
proteins	NULL
are	NULL
directly	NULL
adjacent	NULL
to	NULL
or	NULL
overlap	NULL
the	NULL
DNA	NULL
binding	NULL
domains	NULL
of	NULL
both	NULL
proteins	NULL
.	NULL

These	NULL
two	NULL
potential	NULL
mechanisms	NULL
are	NULL
not	NULL
mutually	NULL
exclusive	NULL
.	NULL

The	NULL
resolution	NULL
of	NULL
these	NULL
models	NULL
will	NULL
await	NULL
the	NULL
direct	NULL
determination	NULL
of	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
Ets-NF-	NULL
<	NULL
B/NFAT-DNA	NULL
ternary	NULL
complex	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
should	NULL
be	NULL
emphasized	NULL
that	NULL
our	NULL
data	NULL
do	NULL
not	NULL
allow	NULL
us	NULL
to	NULL
distinguish	NULL
models	NULL
in	NULL
which	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
proteins	NULL
associate	NULL
directly	NULL
from	NULL
models	NULL
in	NULL
which	NULL
accessory	NULL
or	NULL
bridging	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
the	NULL
interaction	NULL
.	NULL

An	NULL
inducible	NULL
T-cell	NULL
enhancon	NULL
composed	NULL
of	NULL
Ets	NULL
,	NULL
NF-KB/	NULL
NFAT	NULL
,	NULL
and	NULL
AP1	NULL
proteins	NULL
.	NULL

Multiple	NULL
inducible	NULL
T-cell	NULL
enhancers	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
contain	NULL
adjacent	NULL
or	NULL
overlapping	NULL
functionally	NULL
important	NULL
binding	NULL
sites	NULL
for	NULL
Ets	NULL
,	NULL
NF-kB/NFAT	NULL
,	NULL
and	NULL
API	NULL
proteins	NULL
(	NULL
18	NULL
,	NULL
42	NULL
,	NULL
44	NULL
,	NULL
66	NULL
,	NULL
87	NULL
,	NULL
101	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
these	NULL
proteins	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
regulating	NULL
inducible	NULL
T-cell	NULL
gene	NULL
expression	NULL
.	NULL

It	NULL
was	NULL
shown	NULL
previously	NULL
that	NULL
multiple	NULL
Ets	NULL
proteins	NULL
can	NULL
associate	NULL
directly	NULL
with	NULL
each	NULL
of	NULL
the	NULL
Jun	NULL
proteins	NULL
(	NULL
3	NULL
,	NULL
91	NULL
)	NULL
.	NULL

This	NULL
interaction	NULL
can	NULL
occur	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
and	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
Ets	NULL
domains	NULL
of	NULL
the	NULL
Ets	NULL
proteins	NULL
and	NULL
the	NULL
basic	NULL
domains	NULL
of	NULL
the	NULL
Jun	NULL
proteins	NULL
.	NULL

Similarly	NULL
,	NULL
previous	NULL
reports	NULL
have	NULL
demonstrated	NULL
physical	NULL
interactions	NULL
between	NULL
NF-	NULL
«	NULL
kB	NULL
and	NULL
AP1	NULL
and	NULL
between	NULL
NFAT	NULL
and	NULL
AP1	NULL
(	NULL
9	NULL
,	NULL
43	NULL
,	NULL
72	NULL
,	NULL
92	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
interaction	NULL
occurs	NULL
between	NULL
the	NULL
basic	NULL
domains	NULL
of	NULL
Jun	NULL
or	NULL
Fos	NULL
and	NULL
the	NULL
Rel	NULL
HD	NULL
of	NULL
p65	NULL
but	NULL
not	NULL
of	NULL
p50	NULL
(	NULL
92	NULL
)	NULL
.	NULL

When	NULL
taken	NULL
together	NULL
with	NULL
these	NULL
previous	NULL
results	NULL
,	NULL
our	NULL
finding	NULL
of	NULL
a	NULL
functionally	NULL
important	NULL
physical	NULL
interaction	NULL
between	NULL
Ets	NULL
and	NULL
proteins	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
the	NULL
assembly	NULL
of	NULL
a	NULL
multiprotein	NULL
enhancon	NULL
composed	NULL
of	NULL
Ets	NULL
,	NULL
NF-	NULL
<	NULL
B/NFAT	NULL
,	NULL
and	NULL
AP1	NULL
proteins	NULL
may	NULL
be	NULL
a	NULL
critical	NULL
step	NULL
in	NULL
activating	NULL
inducible	NULL
T-cell	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
assembly	NULL
of	NULL
such	NULL
enhan-cons	NULL
would	NULL
involve	NULL
both	NULL
protein	NULL
DNA	NULL
interactions	NULL
and	NULL
protein-protein	NULL
interactions	NULL
.	NULL

In	NULL
one	NULL
such	NULL
model	NULL
,	NULL
for	NULL
example	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
to	NULL
cognate	NULL
binding	NULL
sites	NULL
on	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
could	NULL
facilitate	NULL
the	NULL
DNA-independent	NULL
binding	NULL
of	NULL
AP1	NULL
to	NULL
the	NULL
enhancer	NULL
.	NULL

The	NULL
assembly	NULL
of	NULL
this	NULL
type	NULL
of	NULL
tripartite	NULL
protein	NULL
structure	NULL
might	NULL
be	NULL
facilitated	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
Jun	NULL
proteins	NULL
bind	NULL
to	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-kB	NULL
,	NULL
while	NULL
Ets	NULL
proteins	NULL
bind	NULL
to	NULL
the	NULL
p50	NULL
(	NULL
but	NULL
not	NULL
to	NULL
the	NULL
p65	NULL
)	NULL
subunit	NULL
.	NULL

Support	NULL
Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
for	NULL
such	NULL
an	NULL
enhancon	NULL
model	NULL
derives	NULL
from	NULL
previous	NULL
studies	NULL
that	NULL
have	NULL
demonstrated	NULL
synergistic	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
by	NULL
overexpression	NULL
of	NULL
AP1	NULL
and	NULL
NF-kB	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
lacks	NULL
an	NULL
AP1	NULL
binding	NULL
site	NULL
(	NULL
92	NULL
)	NULL
.	NULL

The	NULL
notion	NULL
of	NULL
a	NULL
multiprotein	NULL
enhancon	NULL
that	NULL
regulates	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
multiple	NULL
T-cell	NULL
genes	NULL
has	NULL
a	NULL
number	NULL
of	NULL
attractive	NULL
features	NULL
.	NULL

First	NULL
,	NULL
such	NULL
a	NULL
model	NULL
might	NULL
help	NULL
to	NULL
explain	NULL
how	NULL
T	NULL
cells	NULL
integrate	NULL
multiple	NULL
activation	NULL
signals	NULL
to	NULL
precisely	NULL
regulate	NULL
coordinate	NULL
changes	NULL
in	NULL
gene	NULL
expression	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
Elf-1	NULL
requires	NULL
both	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
3a	NULL
)	NULL
and	NULL
its	NULL
release	NULL
from	NULL
Rb	NULL
(	NULL
103	NULL
)	NULL
,	NULL
which	NULL
is	NULL
mediated	NULL
by	NULL
cyclin-dependent	NULL
kinases	NULL
(	NULL
17	NULL
,	NULL
23	NULL
,	NULL
36	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
requires	NULL
the	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
degradation	NULL
of	NULL
IxB	NULL
(	NULL
4-6	NULL
,	NULL
26	NULL
,	NULL
94	NULL
)	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
NFAT	NULL
requires	NULL
the	NULL
calcium-dependent	NULL
phosphatase	NULL
calcineurin	NULL
(	NULL
24	NULL
,	NULL
59	NULL
)	NULL
,	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
AP1	NULL
involves	NULL
both	NULL
the	NULL
transcriptional	NULL
up-regulation	NULL
of	NULL
the	NULL
Jun	NULL
and	NULL
Fos	NULL
proteins	NULL
and	NULL
their	NULL
phosphorylation	NULL
(	NULL
34	NULL
,	NULL
46	NULL
,	NULL
69	NULL
,	NULL
94	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
activation	NULL
of	NULL
each	NULL
of	NULL
these	NULL
signaling	NULL
pathways	NULL
would	NULL
be	NULL
required	NULL
for	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
intact	NULL
enhancons	NULL
,	NULL
a	NULL
prediction	NULL
that	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
known	NULL
requirement	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
multiple	NULL
signaling	NULL
pathways	NULL
in	NULL
the	NULL
process	NULL
of	NULL
T-cell	NULL
activation	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
large	NULL
number	NULL
of	NULL
potential	NULL
complexes	NULL
that	NULL
can	NULL
be	NULL
formed	NULL
between	NULL
different	NULL
Ets	NULL
,	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
,	NULL
and	NULL
AP1	NULL
family	NULL
members	NULL
provides	NULL
a	NULL
dynamic	NULL
mechanism	NULL
for	NULL
the	NULL
fine	NULL
regulation	NULL
of	NULL
multiple	NULL
inducible	NULL
T-cell	NULL
genes	NULL
with	NULL
a	NULL
minimum	NULL
number	NULL
of	NULL
distinct	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
requirement	NULL
for	NULL
DNA	NULL
in	NULL
the	NULL
Ets-NF-	NULL
«	NULL
B/NFAT	NULL
interaction	NULL
has	NULL
important	NULL
implications	NULL
for	NULL
the	NULL
differential	NULL
regulation	NULL
of	NULL
inducible	NULL
T-cell	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
high	NULL
degree	NULL
of	NULL
conservation	NULL
of	NULL
protein-protein	NULL
interaction	NULL
sites	NULL
among	NULL
multiple	NULL
Ets	NULL
,	NULL
AP1	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
family	NULL
members	NULL
suggests	NULL
that	NULL
it	NULL
might	NULL
be	NULL
possible	NULL
to	NULL
form	NULL
many	NULL
different	NULL
multiprotein	NULL
complexes	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
DNA-independent	NULL
nature	NULL
of	NULL
the	NULL
Ets-AP1	NULL
and	NULL
NF-kB-API1	NULL
interactions	NULL
suggests	NULL
that	NULL
such	NULL
multiprotein	NULL
complexes	NULL
could	NULL
be	NULL
formed	NULL
in	NULL
solution	NULL
and	NULL
could	NULL
bind	NULL
to	NULL
DNA	NULL
elements	NULL
containing	NULL
a	NULL
single	NULL
Ets	NULL
,	NULL
AP1	NULL
,	NULL
or	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
site	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
the	NULL
Ets-NF-	NULL
«	NULL
B/NFAT	NULL
interaction	NULL
requires	NULL
binding	NULL
sites	NULL
for	NULL
both	NULL
proteins	NULL
suggests	NULL
a	NULL
mechanism	NULL
for	NULL
restricting	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
intact	NULL
enhancon	NULL
to	NULL
DNA	NULL
elements	NULL
containing	NULL
both	NULL
sites	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
distinct	NULL
fine	NULL
specificities	NULL
of	NULL
binding	NULL
of	NULL
different	NULL
Ets	NULL
and	NULL
NF-	NULL
«	NULL
B/NFAT	NULL
family	NULL
members	NULL
(	NULL
12	NULL
,	NULL
27	NULL
,	NULL
41	NULL
,	NULL
47	NULL
,	NULL
57	NULL
,	NULL
74	NULL
,	NULL
90	NULL
,	NULL
100	NULL
,	NULL
102	NULL
,	NULL
105	NULL
)	NULL
suggest	NULL
that	NULL
only	NULL
a	NULL
limited	NULL
number	NULL
of	NULL
specific	NULL
complexes	NULL
would	NULL
be	NULL
able	NULL
to	NULL
assemble	NULL
on	NULL
individual	NULL
promoter	NULL
and	NULL
enhancer	NULL
elements	NULL
,	NULL
thereby	NULL
conferring	NULL
a	NULL
degree	NULL
of	NULL
sequence	NULL
specificity	NULL
to	NULL
the	NULL
assembly	NULL
process	NULL
.	NULL

The	NULL
Ets-NF-KB/NFAT	NULL
association	NULL
as	NULL
a	NULL
target	NULL
for	NULL
immunosuppressive	NULL
and	NULL
antiviral	NULL
therapies	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
the	NULL
Ets-interaction	NULL
is	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
HIV	NULL
enhancers	NULL
and	NULL
that	NULL
this	NULL
interaction	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
that	NULL
binds	NULL
to	NULL
DNA	NULL
but	NULL
fails	NULL
to	NULL
interact	NULL
with	NULL
Ets	NULL
proteins	NULL
suggests	NULL
that	NULL
this	NULL
protein-protein	NULL
interaction	NULL
might	NULL
represent	NULL
a	NULL
novel	NULL
target	NULL
for	NULL
immunosuppressive	NULL
therapies	NULL
.	NULL

More	NULL
generally	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
physical	NULL
interactions	NULL
between	NULL
Ets	NULL
,	NULL
AP1	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
kB/NFAT	NULL
proteins	NULL
are	NULL
important	NULL
in	NULL
regulating	NULL
inducible	NULL
T-cell	NULL
gene	NULL
expression	NULL
suggests	NULL
that	NULL
molecules	NULL
that	NULL
disrupt	NULL
these	NULL
interactions	NULL
may	NULL
be	NULL
useful	NULL
in	NULL
down-regulating	NULL
T-cell	NULL
function	NULL
in	NULL
vivo	NULL
.	NULL

Such	NULL
molecules	NULL
might	NULL
also	NULL
be	NULL
useful	NULL
anti-HIV	NULL
reagents	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
G.	NULL
Nabel	NULL
for	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
HIV-1	NULL
plasmids	NULL
;	NULL
A.	NULL
Rao	NULL
for	NULL
NFATp	NULL
plasmid	NULL
;	NULL
and	NULL
C.	NULL
Simon	NULL
for	NULL
PU.1	NULL
plasmid	NULL
.	NULL

W.	NULL
Jiang	NULL
provided	NULL
expert	NULL
technical	NULL
assistance	NULL
.	NULL

We	NULL
thank	NULL
P.	NULL
Lawrey	NULL
for	NULL
help	NULL
with	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
G.	NULL
Schneider	NULL
and	NULL
L.	NULL
Gottschalk	NULL
for	NULL
Ets-NF-	NULL
«	NULL
B/NFAT	NULL
PHYSICAL	NULL
INTERACTION	NULL
_	NULL
3571	NULL
help	NULL
with	NULL
preparation	NULL
of	NULL
the	NULL
illustrations	NULL
.	NULL

M.	NULL
Parmacek	NULL
,	NULL
C.	NULL
Simon	NULL
,	NULL
T.	NULL
McKeithan	NULL
,	NULL
and	NULL
C.	NULL
Thompson	NULL
provided	NULL
critical	NULL
reviews	NULL
of	NULL
the	NULL
manu-script	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
NIH	NULL
to	NULL
J.M.L	NULL
.	NULL

(	NULL
AI29637	NULL
)	NULL
and	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
DOD	NULL
to	NULL
A.G.B	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Baeverle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IxB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546	NULL
.	NULL

2	NULL
.	NULL

Bassuk	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
J.	NULL
Leiden	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Ets	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
development	NULL
and	NULL
function	NULL
of	NULL
the	NULL
mammalian	NULL
immune	NULL
system	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

64:65-104	NULL
.	NULL

3	NULL
.	NULL

Bassuk	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
direct	NULL
physical	NULL
association	NULL
between	NULL
ETS	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Immunity	NULL
3:223-237	NULL
.	NULL

3a.Bassuk	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

4	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
R.	NULL
I.	NULL
Scheinman	NULL
,	NULL
S.	NULL
Haskill	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
B.	NULL
,	NULL
Jr.	NULL
1992	NULL
.	NULL

IxB	NULL
interacts	NULL
with	NULL
the	NULL
nuclear	NULL
localization	NULL
sequences	NULL
of	NULL
the	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
cytoplasmic	NULL
retention	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1899-1913	NULL
.	NULL

5	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
C.	NULL
Sha	NULL
,	NULL
R.	NULL
T.	NULL
Bronson	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Constitutive	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
enhanced	NULL
granulopoiesis	NULL
,	NULL
and	NULL
neonatal	NULL
lethality	NULL
in	NULL
IxBa-deficient	NULL
mice	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

92736-2746	NULL
.	NULL

6	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
C.	NULL
Sha	NULL
,	NULL
R.	NULL
T.	NULL
Bronson	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Embryonic	NULL
lethality	NULL
and	NULL
liver	NULL
degeneration	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
RelA	NULL
component	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
376:167-170	NULL
.	NULL

7	NULL
.	NULL

Beitel	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
S.	NULL
Tuck	NULL
,	NULL
I.	NULL
Greenwald	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
Horvitz	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Caeno-rhabditis	NULL
elegans	NULL
gene	NULL
lin-1	NULL
encodes	NULL
an	NULL
ETS-domain	NULL
protein	NULL
and	NULL
defines	NULL
a	NULL
branch	NULL
of	NULL
the	NULL
vulval	NULL
induction	NULL
pathway	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:3149-3162	NULL
.	NULL

8	NULL
.	NULL

Ben	NULL
,	NULL
D.	NULL
Y.	NULL
,	NULL
E.	NULL
B.	NULL
Giddens	NULL
,	NULL
K.	NULL
Letwin	NULL
,	NULL
and	NULL
A.	NULL
Bernstein	NULL
.	NULL

1991	NULL
.	NULL

Erythroleu-kemia	NULL
induction	NULL
by	NULL
Friend	NULL
murine	NULL
leukemia	NULL
virus	NULL
:	NULL
insertional	NULL
activation	NULL
of	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
ets	NULL
gene	NULL
family	NULL
,	NULL
Fli-1	NULL
,	NULL
closely	NULL
linked	NULL
to	NULL
c-ets-1	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:908-918	NULL
.	NULL

9	NULL
.	NULL

Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
X.	NULL
Mao	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
C.	NULL
Y.	NULL
Wang	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kovary	NULL
,	NULL
J.	NULL
M.	NULL
Leiden	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NFAT-1	NULL
DNA	NULL
binding	NULL
complex	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fra-1	NULL
and	NULL
JunB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1911-1919	NULL
.	NULL

10	NULL
.	NULL

Bories	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
D.	NULL
M.	NULL
Willerford	NULL
,	NULL
D.	NULL
Grevin	NULL
,	NULL
L.	NULL
Davidson	NULL
,	NULL
A.	NULL
Camus	NULL
,	NULL
P.	NULL
Martin	NULL
,	NULL
D.	NULL
Stehelin	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Alt	NULL
.	NULL

1995	NULL
.	NULL

Increased	NULL
T-cell	NULL
apoptosis	NULL
and	NULL
terminal	NULL
B-cell	NULL
differentiation	NULL
induced	NULL
by	NULL
inactivation	NULL
of	NULL
the	NULL
Ets-1	NULL
proto-oncogene	NULL
.	NULL

Nature	NULL
377:635-638	NULL
.	NULL

11	NULL
.	NULL

Boulukos	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
P.	NULL
Pognonec	NULL
,	NULL
E.	NULL
Sariban	NULL
,	NULL
M.	NULL
Bailly	NULL
,	NULL
C.	NULL
Lagrou	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1990	NULL
.	NULL

Rapid	NULL
and	NULL
transient	NULL
expression	NULL
of	NULL
Ets2	NULL
in	NULL
mature	NULL
macro-phages	NULL
following	NULL
stimulation	NULL
with	NULL
eMGF	NULL
,	NULL
LPS	NULL
,	NULL
and	NULL
PKC	NULL
activators	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4401-409	NULL
.	NULL

12	NULL
.	NULL

Brown	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1992	NULL
.	NULL

Specificities	NULL
of	NULL
protein-protein	NULL
and	NULL
protein-DNA	NULL
interaction	NULL
of	NULL
GABP	NULL
alpha	NULL
and	NULL
two	NULL
newly	NULL
defined	NULL
ets-related	NULL
proteins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

62502-2512	NULL
.	NULL

13	NULL
.	NULL

Brownell	NULL
,	NULL
E.	NULL
,	NULL
N.	NULL
Mittereder	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
human	NULL
rel	NULL
protooncogene	NULL
cDNA	NULL
containing	NULL
an	NULL
Alu	NULL
fragment	NULL
as	NULL
a	NULL
potential	NULL
coding	NULL
exon	NULL
.	NULL

Oncogene	NULL
4:935-942	NULL
.	NULL

14	NULL
.	NULL

Bruder	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
G.	NULL
Heidecker	NULL
,	NULL
T.-H.	NULL
Tan	NULL
,	NULL
J.	NULL
C.	NULL
Weske	NULL
,	NULL
D.	NULL
Derse	NULL
,	NULL
and	NULL
U.	NULL
R.	NULL
Rapp	NULL
.	NULL

1993	NULL
.	NULL

Oncogene	NULL
activation	NULL
of	NULL
HIV-LTR-driven	NULL
expression	NULL
via	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:5229-5234	NULL
.	NULL

15	NULL
.	NULL

Chang	NULL
,	NULL
P.-Y	NULL
.	NULL

,	NULL
K.	NULL
Stellrecht	NULL
,	NULL
S.	NULL
Melana	NULL
,	NULL
and	NULL
B.	NULL
G.-T.	NULL
Pogo	NULL
.	NULL

1994	NULL
.	NULL

Elements	NULL
in	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
HIV-1	NULL
that	NULL
interact	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
persistently	NULL
infected	NULL
with	NULL
vaccinia	NULL
virus	NULL
.	NULL

Virus	NULL
Res	NULL
.	NULL

34:127-138	NULL
.	NULL

16	NULL
.	NULL

Clark	NULL
,	NULL
N.	NULL
M.	NULL
,	NULL
M.	NULL
C.	NULL
Hannibal	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Markovitz	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Peri-kB	NULL
site	NULL
mediates	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
enhancer	NULL
activation	NULL
in	NULL
monocytes	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:4854-4862	NULL
.	NULL

17	NULL
.	NULL

Cobrinik	NULL
,	NULL
D.	NULL
,	NULL
S.	NULL
F.	NULL
Dowdy	NULL
,	NULL
P.	NULL
W.	NULL
Hinds	NULL
,	NULL
S.	NULL
Mittnacht	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Weinberg	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
retinoblastoma	NULL
protein	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
cycling	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17:312-3155	NULL
.	NULL

18	NULL
.	NULL

Cockerill	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
A.	NULL
G.	NULL
Bert	NULL
,	NULL
G.	NULL
R.	NULL
Ryan	NULL
,	NULL
J.	NULL
R.	NULL
Gamble	NULL
,	NULL
M.	NULL
A.	NULL
Vadas	NULL
,	NULL
and	NULL
P.	NULL
N.	NULL
Cockerill	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
E-selectin	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
by	NULL
cyclosporin	NULL
A	NULL
and	NULL
the	NULL
T-cell	NULL
transcription	NULL
factor	NULL
NFAT	NULL
.	NULL

Blood	NULL
86:2689-2698	NULL
.	NULL

19	NULL
.	NULL

Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
M.	NULL
F.	NULL
Shannon	NULL
,	NULL
A.	NULL
G.	NULL
Bert	NULL
,	NULL
G.	NULL
R.	NULL
Ryan	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Vadas	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor/interleukin	NULL
3	NULL
locus	NULL
is	NULL
regulated	NULL
by	NULL
an	NULL
inducible	NULL
cyclosporin	NULL
A-sensitive	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2466-2470	NULL
.	NULL

20	NULL
.	NULL

Crepieux	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
Coll	NULL
,	NULL
and	NULL
D.	NULL
Stehelin	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
Ets	NULL
family	NULL
of	NULL
proteins	NULL
:	NULL
weak	NULL
modulators	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
quest	NULL
for	NULL
transcriptional	NULL
partners	NULL
.	NULL

Crit	NULL
.	NULL

Rev	NULL
.	NULL

Oncogenesis	NULL
5:615-638	NULL
.	NULL

21	NULL
.	NULL

Demarchi	NULL
,	NULL
F.	NULL
,	NULL
P.	NULL
D'Agaro	NULL
,	NULL
A.	NULL
Falaschi	NULL
,	NULL
and	NULL
M.	NULL
Giacca	NULL
.	NULL

1993	NULL
.	NULL

In	NULL
vivo	NULL
foot-printing	NULL
analysis	NULL
of	NULL
constitutive	NULL
and	NULL
inducible	NULL
protein-DNA	NULL
interactions	NULL
at	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:7450-7460	NULL
.	NULL

22	NULL
.	NULL

Doerre	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
Sista	NULL
,	NULL
S.-C.	NULL
Sun	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
c-rel	NULL
protooncogene	NULL
product	NULL
represses	NULL
NF-kB	NULL
p65-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
type	NULL
1	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:1023-1027	NULL
.	NULL

3572	NULL
23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

BASSUK	NULL
ET	NULL
AL	NULL
.	NULL

Ewen	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
H.	NULL
K.	NULL
Sluss	NULL
,	NULL
C.	NULL
J.	NULL
Sherr	NULL
,	NULL
H.	NULL
Matsushime	NULL
,	NULL
J.	NULL
Kato	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Livingston	NULL
.	NULL

1993	NULL
.	NULL

Functional	NULL
interactions	NULL
of	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
with	NULL
mammalian	NULL
D-type	NULL
cyclins	NULL
.	NULL

Cell	NULL
73:487-497	NULL
.	NULL

Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
B.	NULL
Corthesy	NULL
,	NULL
R.	NULL
J.	NULL
Bram	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1991	NULL
.	NULL

Nuclear	NULL
association	NULL
of	NULL
a	NULL
T-cell	NULL
transcription	NULL
factor	NULL
blocked	NULL
by	NULL
FK-506	NULL
and	NULL
cyclosporin	NULL
A	NULL
.	NULL

Nature	NULL
352:803-807	NULL
.	NULL

Gaynor	NULL
,	NULL
R.	NULL
1992	NULL
.	NULL

Cellular	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
.	NULL

AIDS	NULL
6:347-363	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
in	NULL
vitro	NULL
of	NULL
NF-kB	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
inhibitor	NULL
IxB	NULL
.	NULL

Nature	NULL
344:678-682	NULL
.	NULL

Giovane	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Pintzas	NULL
,	NULL
S.	NULL
M.	NULL
Maira	NULL
,	NULL
P.	NULL
Sobieszczuk	NULL
,	NULL
and	NULL
B.	NULL
Wasylyk	NULL
.	NULL

1994	NULL
.	NULL

Net	NULL
,	NULL
a	NULL
new	NULL
ets	NULL
transcription	NULL
factor	NULL
that	NULL
is	NULL
activated	NULL
by	NULL
Ras	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:1502-1513	NULL
.	NULL

Gottschalk	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
D.	NULL
M.	NULL
Giannola	NULL
,	NULL
and	NULL
S.	NULL
G.	NULL
Emerson	NULL
.	NULL

1993	NULL
.	NULL

Molecular	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
:	NULL
inducible	NULL
T	NULL
cell-restricted	NULL
expression	NULL
requires	NULL
intact	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1681-1692	NULL
.	NULL

Griffin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
T.	NULL
M.	NULL
Folks	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
339:70-73	NULL
.	NULL

Hagman	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1992	NULL
.	NULL

An	NULL
inhibitory	NULL
carboxyl-terminal	NULL
domain	NULL
in	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
mediates	NULL
differential	NULL
binding	NULL
of	NULL
ETS	NULL
family	NULL
factors	NULL
to	NULL
promoter	NULL
sequences	NULL
of	NULL
the	NULL
mb-1	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:8889-8893	NULL
.	NULL

Hahn	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
B.	NULL
Wasylyk	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
oncoprotein	NULL
v-Ets	NULL
is	NULL
less	NULL
selective	NULL
in	NULL
DNA	NULL
binding	NULL
than	NULL
c-Ets-1	NULL
due	NULL
to	NULL
the	NULL
C-terminal	NULL
sequence	NULL
change	NULL
.	NULL

Oncogene	NULL
9:2499-2512	NULL
.	NULL

Hannibal	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
D.	NULL
M.	NULL
Markovitz	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1994	NULL
.	NULL

Multiple	NULL
cis-acting	NULL
elements	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
enhancer	NULL
mediate	NULL
the	NULL
response	NULL
to	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
by	NULL
antigen	NULL
in	NULL
a	NULL
T-cell	NULL
hybridoma	NULL
line	NULL
.	NULL

Blood	NULL
83:1839-1846	NULL
.	NULL

Heydemann	NULL
,	NULL
A.	NULL
,	NULL
G.	NULL
Juang	NULL
,	NULL
K.	NULL
Hennesy	NULL
,	NULL
M.	NULL
Parmacek	NULL
,	NULL
and	NULL
C.	NULL
Simon	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
myeloid	NULL
cell-specific	NULL
c-fos	NULL
promoter	NULL
is	NULL
regulated	NULL
by	NULL
Sp1	NULL
,	NULL
PU.1	NULL
,	NULL
and	NULL
a	NULL
novel	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1676-1686	NULL
.	NULL

Hilberg	NULL
,	NULL
F.	NULL
,	NULL
A.	NULL
Aguzzi	NULL
,	NULL
N.	NULL
Howells	NULL
,	NULL
and	NULL
E.	NULL
F.	NULL
Wagner	NULL
.	NULL

1993.	NULL
c-jun	NULL
is	NULL
essential	NULL
for	NULL
normal	NULL
mouse	NULL
development	NULL
and	NULL
hepatogenesis	NULL
.	NULL

Nature	NULL
365:179-181	NULL
.	NULL

Hilfinger	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
N.	NULL
Clark	NULL
,	NULL
M.	NULL
Smith	NULL
,	NULL
K.	NULL
Robinson	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Markovitz	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
enhancer	NULL
in	NULL
monocytes	NULL
at	NULL
various	NULL
stages	NULL
of	NULL
differentiation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67	NULL
:	NULL
4448-4453	NULL
.	NULL

Hinds	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
S.	NULL
Mittnacht	NULL
,	NULL
V.	NULL
Dulic	NULL
,	NULL
A.	NULL
Arnold	NULL
,	NULL
S.	NULL
I.	NULL
Reed	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Weinberg	NULL
.	NULL

1992	NULL
.	NULL

Regulation	NULL
of	NULL
retinoblastoma	NULL
protein	NULL
functions	NULL
by	NULL
ectopic	NULL
expression	NULL
of	NULL
human	NULL
cyclins	NULL
.	NULL

Cell	NULL
70:993-1006	NULL
.	NULL

Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
D.	NULL
J.	NULL
Thomas	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
X.	NULL
Li	NULL
,	NULL
U.	NULL
Francke	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1995	NULL
.	NULL

NFATc3	NULL
,	NULL
a	NULL
lymphoid-specific	NULL
NFATc	NULL
family	NULL
member	NULL
that	NULL
is	NULL
calcium-regulated	NULL
and	NULL
exhibits	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificity	NULL
.	NULL

Am	NULL
.	NULL

Soc	NULL
.	NULL

Biochem	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

270:19898-19907	NULL
.	NULL

Hodge	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
L.	NULL
Robinson	NULL
,	NULL
D.	NULL
Watson	NULL
,	NULL
J.	NULL
Lautenberger	NULL
,	NULL
X.	NULL
K.	NULL
Zhang	NULL
,	NULL
M.	NULL
Venanzoni	NULL
,	NULL
and	NULL
A.	NULL
Seth	NULL
.	NULL

1996	NULL
.	NULL

Interaction	NULL
of	NULL
ETS-1	NULL
and	NULL
ERGB/FLI-1	NULL
proteins	NULL
with	NULL
DNA	NULL
is	NULL
modulated	NULL
by	NULL
spacing	NULL
between	NULL
multiple	NULL
binding	NULL
sites	NULL
as	NULL
well	NULL
as	NULL
phosphorylation	NULL
.	NULL

Oncogene	NULL
12:11-18	NULL
.	NULL

Hoey	NULL
,	NULL
T.	NULL
,	NULL
Y.-L.	NULL
Sun	NULL
,	NULL
K.	NULL
Williamson	NULL
,	NULL
and	NULL
X.	NULL
Xu	NULL
.	NULL

1995	NULL
.	NULL

Isolation	NULL
of	NULL
two	NULL
new	NULL
members	NULL
of	NULL
the	NULL
NF-AT	NULL
gene	NULL
family	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
the	NULL
NF-AT	NULL
proteins	NULL
.	NULL

Immunity	NULL
21461-472	NULL
.	NULL

Holzmeister	NULL
,	NULL
J.	NULL
,	NULL
B.	NULL
Ludewig	NULL
,	NULL
G.	NULL
Pauli	NULL
,	NULL
and	NULL
D.	NULL
Simon	NULL
.	NULL

1993	NULL
.	NULL

Sequence	NULL
specific	NULL
binding	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
c-Ets1	NULL
to	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
I	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Com-mun	NULL
.	NULL

197:1229-1233	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
similar	NULL
DNA-binding	NULL
motif	NULL
in	NULL
NFAT	NULL
family	NULL
proteins	NULL
and	NULL
the	NULL
Rel	NULL
homology	NULL
region	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:4138-4145	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Lob	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7:333-342	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
Z	NULL
.	NULL

Miner	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
J.	NULL
N.	NULL
Lambert	NULL
,	NULL
G.	NULL
L.	NULL
Verdine	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
T-cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
calcineurin	NULL
and	NULL
interacts	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
365:352-355	NULL
.	NULL

John	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
B.	NULL
Reeves	NULL
,	NULL
J.-X	NULL
.	NULL

Lin	NULL
,	NULL
R.	NULL
Child	NULL
,	NULL
J.	NULL
M.	NULL
Leiden	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
cell-type-specific	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
-chain	NULL
gene	NULL
expression	NULL
:	NULL
potential	NULL
role	NULL
of	NULL
physical	NULL
interactions	NULL
between	NULL
Elf-1	NULL
,	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:1786-1796	NULL
.	NULL

Jonsen	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Petersen	NULL
,	NULL
Q.	NULL
Xu	NULL
,	NULL
and	NULL
B.	NULL
Graves	NULL
.	NULL

1996	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
cooperative	NULL
function	NULL
of	NULL
inhibitory	NULL
sequences	NULL
in	NULL
Ets-1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:2065-2073	NULL
.	NULL

Kallunki	NULL
,	NULL
T.	NULL
,	NULL
B.	NULL
Su	NULL
,	NULL
I.	NULL
Tsigelny	NULL
,	NULL
H.	NULL
K.	NULL
Sluss	NULL
,	NULL
B.	NULL
Derijard	NULL
,	NULL
G.	NULL
Moore	NULL
,	NULL
R.	NULL
Davis	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1994	NULL
.	NULL

JNK2	NULL
contains	NULL
a	NULL
specificity-determining	NULL
region	NULL
responsible	NULL
for	NULL
efficient	NULL
c-Jun	NULL
binding	NULL
and	NULL
phosphorylation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

15:2996-3007	NULL
.	NULL

Karim	NULL
,	NULL
F.	NULL
D.	NULL
,	NULL
L.	NULL
D.	NULL
Urness	NULL
,	NULL
C.	NULL
S.	NULL
Thummel	NULL
,	NULL
M.	NULL
J.	NULL
Klemsz	NULL
,	NULL
S.	NULL
R.	NULL
McKercher	NULL
,	NULL
A.	NULL
Celada	NULL
,	NULL
B.	NULL
C.	NULL
Van	NULL
,	NULL
R.	NULL
A.	NULL
Maki	NULL
,	NULL
C.	NULL
V.	NULL
Gunther	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Nye	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
ETS-domain	NULL
:	NULL
a	NULL
new	NULL
DNA-binding	NULL
motif	NULL
that	NULL
recognizes	NULL
a	NULL
purine-rich	NULL
core	NULL
48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

S1	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

J.	NULL
ViRoL	NULL
.	NULL

DNA	NULL
sequence	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

41451-1453	NULL
.	NULL

(	NULL
Letter	NULL
.	NULL
)	NULL

Kato	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Matsushime	NULL
,	NULL
S.	NULL
W.	NULL
Hiebert	NULL
,	NULL
M.	NULL
E.	NULL
Ewen	NULL
,	NULL
and	NULL
C.	NULL
J.	NULL
Sherr	NULL
.	NULL

1993	NULL
.	NULL

Direct	NULL
binding	NULL
of	NULL
cyclin	NULL
D	NULL
to	NULL
the	NULL
retinoblastoma	NULL
gene	NULL
product	NULL
(	NULL
pRb	NULL
)	NULL
and	NULL
pRb	NULL
phosphorylation	NULL
by	NULL
the	NULL
cyclin	NULL
D-dependent	NULL
kinase	NULL
CDK4	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:331-342	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
S.	NULL
Vandekerckhove	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
O.	NULL
L.	NULL
Bail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourlisky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

Klement	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
B.	NULL
D.	NULL
Car	NULL
,	NULL
S.	NULL
J.	NULL
Abbondanzo	NULL
,	NULL
G.	NULL
D.	NULL
Powers	NULL
,	NULL
H.	NULL
Bhatt	NULL
,	NULL
C.	NULL
H.	NULL
Chen	NULL
,	NULL
and	NULL
C.	NULL
L.	NULL
Stewart	NULL
.	NULL

1996	NULL
.	NULL

IxBa	NULL
deficiency	NULL
results	NULL
in	NULL
a	NULL
sustained	NULL
NF-kB	NULL
response	NULL
and	NULL
severe	NULL
widespread	NULL
dermatitis	NULL
in	NULL
mice	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:2341-2349	NULL
.	NULL

Lai	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1992	NULL
.	NULL

Ethidium	NULL
bromide	NULL
provides	NULL
a	NULL
simple	NULL
tool	NULL
for	NULL
identifying	NULL
genuine	NULL
DNA-independent	NULL
protein	NULL
associations	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:6958-6962	NULL
.	NULL

Leiden	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
C.-Y	NULL
.	NULL

Wang	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
D.	NULL
M.	NULL
Markovitz	NULL
,	NULL
G.	NULL
J.	NULL
Nabel	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
Ets-related	NULL
transcription	NULL
factor	NULL
,	NULL
Elf-1	NULL
,	NULL
binds	NULL
to	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
regulatory	NULL
elements	NULL
that	NULL
are	NULL
required	NULL
for	NULL
inducible	NULL
trans	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:5890-5897	NULL
.	NULL

Leprince	NULL
,	NULL
D.	NULL
,	NULL
A.	NULL
Gegonne	NULL
,	NULL
J.	NULL
Coll	NULL
,	NULL
T.	NULL
C.	NULL
de	NULL
,	NULL
A.	NULL
Schneeberger	NULL
,	NULL
C.	NULL
Lagrou	NULL
,	NULL
and	NULL
D.	NULL
Stehelin	NULL
.	NULL

1983	NULL
.	NULL

A	NULL
putative	NULL
second	NULL
cell-derived	NULL
oncogene	NULL
of	NULL
the	NULL
avian	NULL
leukaemia	NULL
retrovirus	NULL
E26	NULL
.	NULL

Nature	NULL
306:395-397	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1988	NULL
.	NULL

HTLV-1	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
.	NULL

Nature	NULL
333:776-778	NULL
.	NULL

Li	NULL
,	NULL
X.	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
J.	NULL
Luna	NULL
,	NULL
J.	NULL
Giacal	NULL
D.	NULL
J.	NULL
Th	NULL
L.	NULL
A.	NULL
Ti	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
and	NULL
U.	NULL
Francke	NULL
.	NULL

1995	NULL
.	NULL

Cloning	NULL
and	NULL
chromosomal	NULL
localization	NULL
of	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
genes	NULL
for	NULL
the	NULL
T-cell	NULL
transcription	NULL
factors	NULL
NFATe	NULL
and	NULL
NFATp*	NULL
.	NULL

Cytogenet	NULL
.	NULL

Cell	NULL
Genet	NULL
.	NULL

68:185-191	NULL
.	NULL

Lim	NULL
,	NULL
F.	NULL
,	NULL
N.	NULL
Kraut	NULL
,	NULL
J.	NULL
Frampton	NULL
,	NULL
and	NULL
T.	NULL
Graf	NULL
.	NULL

1992	NULL
.	NULL

DNA	NULL
binding	NULL
by	NULL
c-Ets-1	NULL
,	NULL
but	NULL
not	NULL
v-Ets	NULL
,	NULL
is	NULL
repressed	NULL
by	NULL
an	NULL
intramolecular	NULL
mechanism	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:643-652	NULL
.	NULL

Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1993	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/rel	NULL
transcription	NULL
factor	NULL
and	NULL
IxB	NULL
inhibitor	NULL
system	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

5477-487	NULL
.	NULL

Loh	NULL
,	NULL
C.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Carew	NULL
,	NULL
J.	NULL
Kim	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

T-cell	NULL
receptor	NULL
stimulation	NULL
elicits	NULL
an	NULL
early	NULL
phase	NULL
of	NULL
activation	NULL
and	NULL
a	NULL
later	NULL
phase	NULL
of	NULL
deacti-vation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:3945-3954	NULL
.	NULL

Luo	NULL
,	NULL
C.	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Carew	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

Recombinant	NULL
NFAT1	NULL
(	NULL
NFATp	NULL
)	NULL
is	NULL
regulated	NULL
by	NULL
calcineurin	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
mediates	NULL
transcription	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:3955-3966	NULL
.	NULL

Macleod	NULL
,	NULL
K.	NULL
,	NULL
D.	NULL
Leprince	NULL
,	NULL
and	NULL
D.	NULL
Stehelin	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
ets	NULL
gene	NULL
family	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17:251-256	NULL
.	NULL

(	NULL
Review	NULL
.	NULL
)	NULL

Majello	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
D.	NULL
Luca	NULL
,	NULL
G.	NULL
Hagen	NULL
,	NULL
G.	NULL
Suske	NULL
,	NULL
and	NULL
L.	NULL
Lania	NULL
.	NULL

1994	NULL
.	NULL

Different	NULL
members	NULL
of	NULL
the	NULL
spl	NULL
multigene	NULL
family	NULL
exert	NULL
opposite	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
HIV-1	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22:4914-4921	NULL
.	NULL

Markovitz	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
M.	NULL
Hannibal	NULL
,	NULL
V.	NULL
L.	NULL
Perez	NULL
,	NULL
C.	NULL
Gauntt	NULL
,	NULL
T.	NULL
M.	NULL
Folks	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1990	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
viruses	NULL
(	NULL
HIVs	NULL
)	NULL
:	NULL
a	NULL
specific	NULL
regulatory	NULL
element	NULL
of	NULL
HIV-2	NULL
responds	NULL
to	NULL
stimulation	NULL
of	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:9098-9102	NULL
.	NULL

Markovitz	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
M.	NULL
C.	NULL
Hannibal	NULL
,	NULL
M.	NULL
J.	NULL
Smith	NULL
,	NULL
R.	NULL
Cossman	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1992	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
enhancer	NULL
is	NULL
not	NULL
dependent	NULL
on	NULL
NFAT-1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:3961-3965	NULL
.	NULL

Markovitz	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
M.	NULL
J.	NULL
Smith	NULL
,	NULL
J.	NULL
Hilfinger	NULL
,	NULL
M.	NULL
C.	NULL
Hannibal	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1992	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
enhancer	NULL
is	NULL
dependent	NULL
on	NULL
purine	NULL
box	NULL
and	NULL
«	NULL
B	NULL
regulatory	NULL
elements	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:5479-5484	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
F.	NULL
Saito	NULL
,	NULL
C.	NULL
Hannum	NULL
,	NULL
K.-I	NULL
.	NULL

Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1995	NULL
.	NULL

NFATx	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
family	NULL
that	NULL
is	NULL
expressed	NULL
predominantly	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2697-2706	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
A.	NULL
Tsubio	NULL
,	NULL
J.	NULL
Shlomai	NULL
,	NULL
P.	NULL
Hung	NULL
,	NULL
K.-L.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
cis-acting	NULL
element	NULL
CLEO	NULL
mediates	NULL
induction	NULL
signals	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
recognized	NULL
by	NULL
factors	NULL
related	NULL
to	NULL
AP1	NULL
and	NULL
NFAT	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
:	NULL
7399-7407	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
T.	NULL
K.	NULL
Kerpolla	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
A.	NULL
M.	NULL
Ho	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
J.	NULL
N.	NULL
Lambert	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
G.	NULL
L.	NULL
Verdine	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1993	NULL
.	NULL

Isolation	NULL
of	NULL
the	NULL
cyclosporin-sensitive	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
.	NULL

Science	NULL
262:750-754	NULL
.	NULL

Melet	NULL
,	NULL
F.	NULL
,	NULL
B.	NULL
Motro	NULL
,	NULL
D.	NULL
Rossi	NULL
,	NULL
L.	NULL
Zhang	NULL
,	NULL
and	NULL
A.	NULL
Bernstein	NULL
.	NULL

1996	NULL
.	NULL

Generation	NULL
of	NULL
a	NULL
novel	NULL
Fli-1	NULL
protein	NULL
by	NULL
gene	NULL
targeting	NULL
leads	NULL
to	NULL
a	NULL
defect	NULL
in	NULL
thymus	NULL
development	NULL
and	NULL
a	NULL
delay	NULL
in	NULL
Friend	NULL
virus-induced	NULL
erythroleukemia	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:2708-2718	NULL
.	NULL

Minden	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Lin	NULL
,	NULL
T.	NULL
Smeal	NULL
,	NULL
B.	NULL
Derijard	NULL
,	NULL
M.	NULL
Cobb	NULL
,	NULL
R.	NULL
Davis	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1994	NULL
.	NULL

JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
77:727-736	NULL
.	NULL

Muthusamy	NULL
,	NULL
N.	NULL
,	NULL
K.	NULL
Barton	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1995	NULL
.	NULL

Defective	NULL
activation	NULL
Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

85	NULL
.	NULL

86	NULL
.	NULL

87	NULL
.	NULL

88	NULL
.	NULL

89.	NULL
and	NULL
survival	NULL
of	NULL
T	NULL
cells	NULL
lacking	NULL
the	NULL
Ets-1	NULL
transcription	NULL
factor	NULL
.	NULL

Nature	NULL
377	NULL
:	NULL
639-642	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
326	NULL
:	NULL
711-713	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
1994	NULL
.	NULL

NF-AT-AP-1	NULL
and	NULL
Rel-bZIP	NULL
:	NULL
hybrid	NULL
vigor	NULL
and	NULL
binding	NULL
under	NULL
the	NULL
influence	NULL
.	NULL

Cell	NULL
77:795-798	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
D.	NULL
J.	NULL
Thomas	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1994	NULL
.	NULL

NF-AT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
369:497-502	NULL
.	NULL

Nye	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
M.	NULL
Petersen	NULL
,	NULL
C.	NULL
V.	NULL
Gunther	NULL
,	NULL
M.	NULL
D.	NULL
Jonsen	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1992	NULL
.	NULL

Interaction	NULL
of	NULL
murine	NULL
ets-1	NULL
with	NULL
GGA-binding	NULL
sites	NULL
establishes	NULL
the	NULL
ETS	NULL
domain	NULL
as	NULL
a	NULL
new	NULL
DNA-binding	NULL
motif	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6975-990	NULL
.	NULL

Olson	NULL
,	NULL
M.	NULL
,	NULL
E.	NULL
Scott	NULL
,	NULL
A.	NULL
Hack	NULL
,	NULL
G.	NULL
Su	NULL
,	NULL
D.	NULL
Tenen	NULL
,	NULL
H.	NULL
Singh	NULL
,	NULL
and	NULL
C.	NULL
Simon	NULL
.	NULL

1995	NULL
.	NULL

PU.1	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
early	NULL
myeloid	NULL
gene	NULL
expression	NULL
but	NULL
is	NULL
required	NULL
for	NULL
terminal	NULL
myeloid	NULL
differentiation	NULL
.	NULL

Immunity	NULL
3:703-714	NULL
.	NULL

O'Neill	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
I.	NULL
Rebay	NULL
,	NULL
R.	NULL
Tjian	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
Rubin	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
activities	NULL
of	NULL
two	NULL
Ets-related	NULL
transcription	NULL
factors	NULL
required	NULL
for	NULL
Drosophila	NULL
eye	NULL
development	NULL
are	NULL
modulated	NULL
by	NULL
the	NULL
Ras/MAPK	NULL
pathway	NULL
.	NULL

Cell	NULL
78:137-147	NULL
.	NULL

Pazin	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
P.	NULL
L.	NULL
Sheridan	NULL
,	NULL
K.	NULL
Cannon	NULL
,	NULL
Z.	NULL
Cao	NULL
,	NULL
J.	NULL
G.	NULL
Keck	NULL
,	NULL
J.	NULL
T.	NULL
Ka-donaga	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Jones	NULL
.	NULL

1996	NULL
.	NULL

NF-	NULL
«	NULL
B-mediated	NULL
chromatin	NULL
reconfiguration	NULL
and	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
in	NULL
vitro	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

10:37-49	NULL
.	NULL

Petersen	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
J.	NULL
J.	NULL
Skalicky	NULL
,	NULL
L.	NULL
W.	NULL
Donaldson	NULL
,	NULL
L.	NULL
P.	NULL
McIntosh	NULL
,	NULL
T.	NULL
Alber	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1995	NULL
.	NULL

Modulation	NULL
of	NULL
transcription	NULL
factor	NULL
Ets-1	NULL
DNA	NULL
binding	NULL
:	NULL
DNA-induced	NULL
unfolding	NULL
of	NULL
an	NULL
alpha	NULL
helix	NULL
.	NULL

Science	NULL
269:1866-1869	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1995	NULL
.	NULL

Coordinate	NULL
and	NULL
cooperative	NULL
roles	NULL
for	NULL
the	NULL
NF-AT	NULL
and	NULL
AP-1	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
.	NULL

Immunity	NULL
2473-483	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Y.-L.	NULL
Sun	NULL
,	NULL
L.	NULL
H.	NULL
Glimcher	NULL
,	NULL
and	NULL
T.	NULL
Hoey	NULL
.	NULL

1995	NULL
.	NULL

Novel	NULL
NFAT	NULL
sites	NULL
that	NULL
mediate	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:6299-6310	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
rel-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
251	NULL
:	NULL
1490-1493	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
Z.	NULL
Baeuerle	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
novel	NULL
rel-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65	NULL
kDa	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
251:1490-1493	NULL
.	NULL

Ruff	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
and	NULL
K.	NULL
L.	NULL
Leach	NULL
.	NULL

1995	NULL
.	NULL

Direct	NULL
demonstration	NULL
of	NULL
NFAT	NULL
dephosphorylation	NULL
and	NULL
nuclear	NULL
localization	NULL
in	NULL
activated	NULL
HT-2	NULL
cells	NULL
using	NULL
a	NULL
specific	NULL
NFATp	NULL
polyclonal	NULL
antibody	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:22602-22607	NULL
.	NULL

Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
P.	NULL
C.	NULL
Andrews	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
which	NULL
stimulates	NULL
HIV	NULL
transcription	NULL
in	NULL
synergy	NULL
with	NULL
p65	NULL
.	NULL

Nature	NULL
352:733-736	NULL
.	NULL

Scott	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
M.	NULL
C.	NULL
Simon	NULL
,	NULL
J.	NULL
Anastasi	NULL
,	NULL
and	NULL
H.	NULL
Singh	NULL
.	NULL

1994	NULL
.	NULL

Requirement	NULL
of	NULL
transcription	NULL
factor	NULL
PU.1	NULL
in	NULL
the	NULL
development	NULL
of	NULL
multiple	NULL
hematopoictic	NULL
lineages	NULL
.	NULL

Science	NULL
265:1573-1577	NULL
.	NULL

Seth	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
R.	NULL
Hodge	NULL
,	NULL
D.	NULL
M.	NULL
Thomp	NULL
L.	NULL
Robi	NULL
A.	NULL
Panayiotakis	NULL
,	NULL
D.	NULL
K.	NULL
Watson	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1993	NULL
.	NULL

ETS	NULL
family	NULL
proteins	NULL
activate	NULL
transcription	NULL
from	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
9:1017-1023	NULL
.	NULL

Shannon	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
S.	NULL
R.	NULL
Himes	NULL
,	NULL
and	NULL
L.	NULL
S.	NULL
Coles	NULL
.	NULL

1995	NULL
.	NULL

GM-CSF	NULL
and	NULL
IL-2	NULL
share	NULL
common	NULL
control	NULL
mechanisms	NULL
in	NULL
response	NULL
to	NULL
costimulatory	NULL
signals	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

57:767-773	NULL
.	NULL

Shaw	NULL
,	NULL
K	NULL
.	NULL

T.-¥	NULL
.	NULL

,	NULL
A.	NULL
M.	NULL
Ho	NULL
,	NULL
A.	NULL
Raghavan	NULL
,	NULL
J.	NULL
Kim	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
J	NULL
.	NULL

Park	NULL
,	NULL
S.	NULL
Sharma	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
P.	NULL
C.	NULL
Hogan	NULL
.	NULL

1995	NULL
.	NULL

Immunosuppressive	NULL
drugs	NULL
prevent	NULL
a	NULL
rapid	NULL
dephosphorylation	NULL
of	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
in	NULL
stimulated	NULL
immune	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:11205-11209	NULL
.	NULL

Sheridan	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
C.	NULL
T.	NULL
Sheline	NULL
,	NULL
K.	NULL
Cannon	NULL
,	NULL
M.	NULL
L	NULL
Voz	NULL
,	NULL
M.	NULL
J.	NULL
Pazin	NULL
,	NULL
J.	NULL
T.	NULL
Dadonaga	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Jones	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
by	NULL
the	NULL
90	NULL
.	NULL

91	NULL
.	NULL

92	NULL
.	NULL

93	NULL
.	NULL

94	NULL
.	NULL

95	NULL
.	NULL

96	NULL
.	NULL

97	NULL
.	NULL

98	NULL
.	NULL

99	NULL
.	NULL

100	NULL
.	NULL

101	NULL
.	NULL

102	NULL
.	NULL

103	NULL
.	NULL

104	NULL
.	NULL

105	NULL
.	NULL

106	NULL
.	NULL

107	NULL
.	NULL

108	NULL
.	NULL

Ets-NF-	NULL
«	NULL
B/NFAT	NULL
PHYSICAL	NULL
INTERACTION	NULL
_	NULL
3573	NULL
LEF-1	NULL
HMG	NULL
protein	NULL
on	NULL
nucleosome-assembled	NULL
DNA	NULL
in	NULL
vitro	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:2090-2104	NULL
.	NULL

Shin	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Koshland	NULL
.	NULL

1993	NULL
.	NULL

Ets-related	NULL
protein	NULL
PU.1	NULL
regulates	NULL
expression	NULL
of	NULL
the	NULL
immunoglobulin	NULL
J-chain	NULL
gene	NULL
through	NULL
a	NULL
novel	NULL
Ets-binding	NULL
clement	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2006-2015	NULL
.	NULL

Sieweke	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Tekotte	NULL
,	NULL
J.	NULL
Frampton	NULL
,	NULL
and	NULL
T.	NULL
Graf	NULL
.	NULL

1996	NULL
.	NULL

MafB	NULL
is	NULL
an	NULL
interaction	NULL
partner	NULL
and	NULL
repressor	NULL
of	NULL
Ets-1	NULL
that	NULL
inhibits	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Cell	NULL
85:49-60	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
J.	NULL
Albert	NULL
,	NULL
S.	NULL
Baldwin	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
P.	NULL
Angel	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1993	NULL
.	NULL

Cross-coupling	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
Fos/Jun	NULL
transcription	NULL
factors	NULL
produces	NULL
potentiated	NULL
biological	NULL
function	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3879-3891	NULL
.	NULL

Sumarsono	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Wilson	NULL
,	NULL
M.	NULL
Tymms	NULL
,	NULL
D.	NULL
Venter	NULL
,	NULL
C.	NULL
Corrick	NULL
,	NULL
R.	NULL
Kola	NULL
,	NULL
M.	NULL
Lahoud	NULL
,	NULL
T.	NULL
Papas	NULL
,	NULL
A.	NULL
Seth	NULL
,	NULL
and	NULL
I.	NULL
Kola	NULL
.	NULL

1996	NULL
.	NULL

Down	NULL
's	NULL
syndrome-like	NULL
skeletal	NULL
abnormalities	NULL
in	NULL
Ets2	NULL
transgenic	NULL
mice	NULL
.	NULL

Nature	NULL
379:534-537	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
P.	NULL
A.	NULL
Ganchi	NULL
,	NULL
C.	NULL
Beraud	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Autoregulation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transactivator	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
by	NULL
multiple	NULL
cytoplasmic	NULL
inhibitors	NULL
containing	NULL
ankyrin	NULL
motifs	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:1346-1350	NULL
.	NULL

Tan	NULL
,	NULL
T.-H.	NULL
,	NULL
G.	NULL
P.	NULL
Huang	NULL
,	NULL
A.	NULL
Sica	NULL
,	NULL
P.	NULL
Ghosh	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
D.	NULL
L.	NULL
Longo	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1992	NULL
.	NULL

«	NULL
B	NULL
site-dependent	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
a-chain	NULL
gene	NULL
promoter	NULL
by	NULL
human	NULL
c-Rel	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4067-4075	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
C.	NULL
Y.	NULL
Wang	NULL
,	NULL
I.	NULL
C.	NULL
Ho	NULL
,	NULL
P.	NULL
R.	NULL
Bobjanen	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
S.	NULL
Miesfeldt	NULL
,	NULL
L.	NULL
Zhang	NULL
,	NULL
G.	NULL
J.	NULL
Nabel	NULL
,	NULL
B.	NULL
Karpinski	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1992.	NULL
cis-acting	NULL
sequences	NULL
required	NULL
for	NULL
inducible	NULL
interleukin-2	NULL
enhancer	NULL
function	NULL
bind	NULL
a	NULL
novel	NULL
Ets-related	NULL
protein	NULL
,	NULL
Elf-1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1043-1053	NULL
.	NULL

Treisman	NULL
,	NULL
R.	NULL
1994	NULL
.	NULL

Ternary	NULL
complex	NULL
factors	NULL
:	NULL
growth	NULL
factor	NULL
regulated	NULL
transcriptional	NULL
activators	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

4:96-101	NULL
.	NULL

(	NULL
Review	NULL
.	NULL
)	NULL

Urness	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
and	NULL
C.	NULL
S.	NULL
Thummel	NULL
.	NULL

1990	NULL
.	NULL

Molecular	NULL
interactions	NULL
within	NULL
the	NULL
ecdysone	NULL
regulatory	NULL
hierarchy	NULL
:	NULL
DNA	NULL
binding	NULL
properties	NULL
of	NULL
the	NULL
Drosophila	NULL
ecdysonc-inducible	NULL
E74A	NULL
protein	NULL
.	NULL

Cell	NULL
63:47-61	NULL
.	NULL

Verma	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
J.	NULL
K.	NULL
Stevenson	NULL
,	NULL
E.	NULL
M.	NULL
Schwartz	NULL
,	NULL
D.	NULL
V.	NULL
Antwerp	NULL
,	NULL
and	NULL
S.	NULL
Miyamoto	NULL
.	NULL

1995	NULL
.	NULL

Rel/NF-	NULL
«	NULL
B/I	NULL
«	NULL
B	NULL
family	NULL
:	NULL
intimate	NULL
tales	NULL
of	NULL
association	NULL
and	NULL
dissociation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

92723-2735	NULL
.	NULL

Virbasius	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
C.	NULL
A.	NULL
Virbasius	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Scarpulla	NULL
.	NULL

1993	NULL
.	NULL

Identity	NULL
of	NULL
GABP	NULL
with	NULL
NRF-2	NULL
,	NULL
a	NULL
multisubunit	NULL
activator	NULL
of	NULL
cytochrome	NULL
oxidase	NULL
expres-sion	NULL
,	NULL
reveals	NULL
a	NULL
cellular	NULL
role	NULL
for	NULL
an	NULL
ETS	NULL
domain	NULL
activator	NULL
of	NULL
viral	NULL
promoters	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:380-392	NULL
.	NULL

Wang	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
A.	NULL
G.	NULL
Bassuk	NULL
,	NULL
L.	NULL
H.	NULL
Boise	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
requires	NULL
cooperative	NULL
binding	NULL
of	NULL
Elf-1	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1153-1159	NULL
.	NULL

Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
I.	NULL
C.	NULL
Ho	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992	NULL
.	NULL

Evolutionarily	NULL
conserved	NULL
Ets	NULL
family	NULL
members	NULL
display	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificities	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:1391-1399	NULL
.	NULL

(	NULL
Erratum	NULL
,	NULL
178:1133	NULL
,	NULL
1993	NULL
.	NULL
)	NULL

Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
W.	NULL
G.	NULL
Kaelin	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1993	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
Ets-related	NULL
transcription	NULL
factor	NULL
Elf-1	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
.	NULL

Science	NULL
260:1330-1335	NULL
.	NULL

Wang	NULL
,	NULL
Z.-Q	NULL
.	NULL

,	NULL
C.	NULL
Ovitt	NULL
,	NULL
A.	NULL
E.	NULL
Grigoriadis	NULL
,	NULL
U.	NULL
Moble-Steinlein	NULL
,	NULL
U.	NULL
Ruther	NULL
,	NULL
and	NULL
E.	NULL
F.	NULL
Wagner	NULL
.	NULL

1992	NULL
.	NULL

Bone	NULL
and	NULL
hematopoietic	NULL
defects	NULL
in	NULL
mice	NULL
lacking	NULL
c-fos	NULL
.	NULL

Nature	NULL
360:741-745	NULL
.	NULL

Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
S.	NULL
L.	NULL
Hahn	NULL
,	NULL
and	NULL
A.	NULL
Giovane	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

211:7-18	NULL
.	NULL

(	NULL
Review	NULL
.	NULL
)	NULL

(	NULL
Erratum	NULL
,	NULL
215:907	NULL
.	NULL
)	NULL

Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
P.	NULL
Kerckaert	NULL
,	NULL
and	NULL
B.	NULL
Wasylyk	NULL
,	NULL
1992	NULL
.	NULL

A	NULL
novel	NULL
modulator	NULL
domain	NULL
of	NULL
Ets	NULL
transcription	NULL
factors	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:965-974	NULL
.	NULL

Wesselborg	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
A.	NULL
Fruman	NULL
,	NULL
J.	NULL
K.	NULL
Sagoo	NULL
,	NULL
B.	NULL
E.	NULL
Bierer	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Burakoff	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
physical	NULL
interaction	NULL
between	NULL
calcineurin	NULL
and	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFATp	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:1274-1277	NULL
.	NULL

Xin	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
A.	NULL
Cowie	NULL
,	NULL
P.	NULL
Lachance	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Hassell	NULL
.	NULL

1992	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
PEA3	NULL
,	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
Ets	NULL
oncogene	NULL
family	NULL
that	NULL
is	NULL
differentially	NULL
expressed	NULL
in	NULL
mouse	NULL
embryonic	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:481-496	NULL
.	NULL

